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Abstract 
Heat shock protein (Hsp) B8 is highly expressed in smooth muscle, but the 
expression and function in uterine smooth muscle, or myometrium, during pregnancy 
remains unknown. The goal of this project was to characterize the myometrial expression 
of HspB8 protein in pregnant rats during myometrial programming.  
Immunoblot analysis determined that HspB8 and the co-chaperone Bcl2-
associated athanogene (Bag) 3 protein expression was elevated at mid-gestation at day 
(d)15 and d17 (p<0.05; n=4). The intracellular localization of HspB8 and Bag3 has not 
been well characterized; therefore, spatiotemporal expression in pregnant rat 
myometrium was also determined by immunofluorescence analysis. HspB8 and Bag3 
were predominantly localized to the cytoplasm of myometrial cells and were not found in 
nuclei. To determine whether an HspB8-Bag3 complex existed in myometrial cells 
during pregnancy, co-immunoprecipitation assays were performed. The results 
demonstrated that an HspB8-Bag3 complex was present in vitro and in vivo, at non-
pregnant, d15 and d23. This investigation provides valuable insights into the 
spatiotemporal expression of HspB8 and Bag3 and evidence of formation of a 
heteromeric signaling complex, HspB8-Bag3, in uterine musculature during pregnancy. 
With known roles of these proteins in macroautophagy activation, these results suggest 
that HspB8 and Bag3 could have similar function(s) during myometrial hypertrophy. 
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Chapter One 
Introduction 
 
1.1 Preterm Birth: Clinical Significance 
 Preterm labour in humans can be defined as childbirth occurring prior to the 
optimal human gestation period of 37-42 weeks [1]. Currently, there is no diagnostic 
indicator of preterm labour and following initiation there is no effective method to 
significantly inhibit the process [2]. This is of major concern as premature birth is a key 
factor associated with neonatal mortality and morbidity and has serious long-term health-
related consequences [3]. Premature babies are at high risk of life-long developmental 
disabilities, mental retardation, cerebral palsy, cognitive impairment, cardiovascular 
disease, vision impairment, diabetes and early death [4-6]. United States statistics 
indicate that preterm birth contributes to approximately 85 % of all perinatal deaths and 
approximately ten percent of newborns each year are preterm infants, weighing less than 
2500 g [7]. In Canada, premature birth constituted 7.8 % of all births in 2011-2012 [8]. 
Of all provinces, Alberta and Newfoundland and Labrador showed the highest preterm 
birth rates, 8.3 % and 8.2 %, respectively [8]. Multiple-fetus pregnancies are predisposed 
to delivering prematurely; over 52.2 % of multiple births occur prior to 37 weeks and 
10.7 % before 32 weeks of gestation [9].  
 Preterm labour causes substantial economic burdens on families, communities, 
and the health care system. In 2001, a preterm infant required an average hospital stay of 
12.9 days and a cost of $15,100, whereas an uncomplicated newborn remained in hospital 
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for only 1.9 days with a much lower cost of $600 [10]. The total cost due to preterm/low 
birth weight deliveries in 2001 totalled $5.8 billion in the United States. This figure does 
not include any treatments that were required after parturition with respect to 
developmental disabilities or other health concerns [10]. 
 Major causes of preterm birth fall into three main categories: the first is delivery 
for maternal or fetal complications and labour is induced or the infant is delivered by pre-
labour caesarean section; the second is due to premature rupture of the fetal membranes; 
and the final category is termed idiopathic preterm labour and arises from an unknown 
cause [1]. About 30% of preterm births are due to maternal or fetal infections, 25–30% 
follow premature rupture of fetal membranes and 40–45% are idiopathic [11]. Aside from 
the three main categories, there is also evidence indicating that the increased use of 
obstetric interventions (iatrogenic), including both induction of labour and caesarean 
sections, may result in early delivery [4, 9]. 
 Despite intensive research efforts in obstetrics, the mechanisms resulting in 
preterm birth largely remain unknown; however, it is now clear that the causes of preterm 
birth are multifactorial. According to the literature, the fetal genome contributes signals 
that initiate parturition, ultimately leading to phenotypic changes in the uterine smooth 
muscle or myometrium [12]. Throughout most of a normal gestation period, the 
myometrium remains in a quiescent state but at term switches to an active state that is 
capable of producing contractions forceful enough to expel the fetus. This thesis aims to 
increase our understanding of the mechanisms underlying normal labour, including 
myometrial adaptation and function during pregnancy. This knowledge of normal 
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function may help us acquire a more complete comprehension of the causes of signaling 
asynchrony between mother and fetus in pre-term labour. Future research efforts will 
help to develop effective treatment and prevention strategies for preterm birth. 
 
1.2 Uterus: The Myometrium 
The human uterus is a pear-shaped, muscular organ that is composed of smooth 
muscle and is found in the midline between the bladder and rectum of a woman. This 
hollow reproductive organ is unique to viviparous female mammals and is responsible for 
protecting and nourishing the developing embryo and fetus [13]. The uterus undergoes 
extensive physiological changes throughout the gestational period as it accommodates the 
developing fetus, placenta and amniotic fluid [14]. During gestation, the uterus 
dramatically expands superiorly into the abdominal cavity. A 75 g non-pregnant uterus 
may become a 1300 g uterus at term. In comparison to the non-pregnant uterus, which 
typically has a capacity of 10 ml, the uterus at term has an average capacity of 5 L [15].  
The human uterus is composed of three different tissue layers: the serosa, a thin 
outer connective tissue covering; the myometrium, a thick middle layer of smooth 
muscle; and an inner layer known as the endometrium, comprised of epithelial cells and 
an underlying layer of thick connective tissue [16]. Implantation of the multicellular 
blastocyst normally occurs in the body of the uterus, more specifically into the 
endometrium. The rat myometrium is composed of two distinct muscle layers, the outer 
longitudinal layer and the inner circular layer that work together to generate strong waves 
of contraction to expel multiple fetuses at term (Figure 1.1A). When a cross section of the 
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rat myometrium is viewed under a microscope, the longitudinal layer appears as muscle 
bundles that often surround vascular channels whereas the circular layer is found 
circumferentially next to the endometrium [17].  
 The rat is an often-used model for studying the basic cellular mechanisms of 
smooth muscle contraction in the myometrium. The myometrium is easily obtainable 
from pregnant rats and their gestational period is shorter than the human gestational 
period. In addition, the rat can be manipulated endocrinologically and surgically as the rat 
uterus is bilateral with two horns that extend toward the kidneys (Figure 1.1B,C). The 
bicornuate uterus provides the opportunity to treat one horn differently from the other. 
The work presented in this thesis is based upon the rat model of pregnancy and further 
discussion will focus on the phases of rat myometrial differentiation throughout 
pregnancy (Figure 1.2).  
 
1.3 Phases of Myometrial Differentiation 
  Throughout pregnancy the smooth muscle cells of the myometrium differentiate. 
This differentiation is required to activate the tissue and in turn drive the necessary 
myometrial contractions required for delivery of the fetus. Each distinct phase of 
pregnancy is regulated by mechanical (distension) influences, endocrine influences or 
both [1]. 
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Figure 1.1(A) A diagrammatic representation of a cross section of a rat uterine horn. The 
rat myometrium is composed of two muscle layers, the outer longitudinal layer and the 
inner circular layer that work together to generate strong waves of contraction to expel 
the fetus at term. When a cross section of the myometrium is viewed under a microscope, 
the longitudinal muscle layer appears as muscle bundles that often surround vascular 
channels. The circular muscle layer is found circumferentially next to the endometrium. 
(B) A rat uterus dissected from a non-pregnant Sprague Dawley rat. (C) A cartoon image 
of a pregnant rat uterus demonstrating the two horns that extend toward the kidneys. 
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Figure 1.2 The phases of rat myometrial differentiation throughout pregnancy. The initial 
proliferative phase of gestation, from the non-pregnant (NP) state to ~day (d) 14, is 
characterized by hyperplasia. Around d14 of gestation proliferation decreases and it is 
followed by a synthetic phase in which the myocyte growth switches to a phase of 
hypertrophic growth and it is associated with an increase in the extracellular matrix 
(ECM). At ~d21 of pregnancy the myocytes differentiate further to a contractile 
phenotype, which lasts until ~d23. During this time the myometrium becomes 
spontaneously active, excitable, and highly responsive to uterine agonists. Finally, the 
myometrium enters the labour phase, which is marked by an up-regulation of contractile 
associated proteins (CAP) that allow the myometrium to become activated and able to 
generate highly coordinated contractions that are capable of expelling the fetus. PP= post-
partum. 
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1.3.1 Proliferation 
 In the rat model, the initial proliferative phase of gestation is from a non-pregnant 
state to approximately day (d) 14 of gestation. This phase is characterized by an increase 
in cell number in the myometrium, also known as hyperplasia [18]. Initial studies on 
myometrial cell proliferation conducted by Shynlova et al. [19] indicated increased 
incorporation of 5-bromo-2’-deoxyuridine (BrdU), a nonradioactive analogue of 
thymidine and marker of individual cell proliferation, into uterine myocytes at d6 and d12 
of pregnancy. Furthermore, they noted increased expression of proliferating cell nuclear 
antigen between d6 and d15 of pregnancy. Myocyte proliferation occurs very rapidly and 
predominantly in the longitudinal muscle layer in both the non-gravid and gravid horns of 
unilaterally pregnant rats [18]. Therefore, it has been suggested that the initial phase of 
proliferation is primarily under the control of endocrine signals. During this phase there is 
a significant increase in expression of anti-apoptotic factors, such as B-cell lymphoma 2 
(Bcl2), which may contribute to the increase in cell number [19]. More specifically, 
myometrial proliferation is induced by estrogen-regulated growth factors including 
insulin-like growth factor 1 (IGF1) and epidermal growth factor (EGF) [19]. Shynlova et 
al. found that Igf-1 and Igfbp1 (its associated binding protein) mRNA levels were up-
regulated in the rat myometrium during d6-d12 of gestation [20]. Cell proliferation has 
also been found to be modulated by the PI3K-PKB-mTOR (mammalian target of 
rapamycin) signaling pathway in many tissues, including the myometrium (Figure 1.3) 
[21, 22]. 17β-Estradiol and IGF-1 production result in activation of phosphoinositide-3- 
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Figure 1.3 Cell proliferation modulated by the PI3K-PKB-mTOR (mammalian target of 
rapamycin) signaling pathway. Once insulin or IGFs bind to their appropriate receptors, 
this leads to the recruitment and phosphorylation of the insulin receptor substrate (IRS) 
and successive recruitment of phosphoinositide-3-kinase (PI3K). Subsequent PI3K 
activation is the result of a cascade of phosphorylation reactions but ultimately the most 
prominent effector of PI3K activity is protein kinase B (PKB). PKB promotes target of 
rapamycin complex 1 (TORC1) signaling, by phosphorylating several sites on tumour 
suppressor tuberous sclerosis complex 2 (TSC2), which relieves inhibition of Ras 
homolog enriched in brain (RHEB; a member of the Ras superfamily of GTPases) and 
thus activates TORC1. The two most characterized targets of mTORC1 are eukaryotic 
initiation factor 4E (eIF4E)-binding protein (4EBP1) and ribosomal S6 kinase (SK6). 
4EBP1 is inactivated by mTOR phosphorylation, resulting in the release of eIF4E to 
promote translation. Furthermore, activation of mTORC1 causes initiation of protein 
translation by phosphorylating S6K1. S6K1 then phosphorylates the S6 protein of the 
40S ribosomal subunit and leads to increased ribosomal biogenesis and ultimately 
increased protein synthesis. Adapted from Russell et al., 2011 [22]. P= phosphorylation 
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kinase (PI3K) signaling, which has been found to cause cell proliferation and growth in 
reproductive tissues [20, 23, 24]. Once insulin or IGFs bind to their appropriate receptors, 
this leads to the recruitment and phosphorylation of the insulin receptor substrate (IRS) 
and successive recruitment of PI3K [25, 26]. Subsequent PI3K activation is the result of a 
cascade of phosphorylation reactions but ultimately the most prominent effector of PI3K 
activity is protein kinase B (PKB) [21]. PKB is a serine (Ser)/threonine (Thr) kinase that 
is able to positively regulate mTOR [27-29]. PKB promotes target of rapamycin complex 
1 (TORC1)- one of the two multiprotein complexes formed by mTOR- signaling, by 
phosphorylating several sites on tumour suppressor tuberous sclerosis complex 2, which 
relieves inhibition of Ras homolog enriched in brain (a member of the Ras superfamily of 
GTPases) and thus activates TORC1 [30-32]. Activation of the mTORC1 pathway results 
in activation of protein synthesis, metabolism, ribosome biogenesis and transcription. The 
two most characterized targets of mTORC1 are eukaryotic initiation factor 4E (eIF4E)-
binding protein (4EBP1) and ribosomal S6 kinase (SK6). 4EBP1 negatively regulates the 
assembly of initiation factors as it binds and sequesters eIF4E, which inhibits the 
recruitment of the translation initiation complex required for protein synthesis [33, 34]. 
4EBP1 is inactivated by mTOR phosphorylation, resulting in the release of eIF4E to 
promote translation [35]. Furthermore, activation of mTORC1 causes initiation of protein 
translation by phosphorylating S6K1. S6K1 then phosphorylates the S6 protein of the 
40S ribosomal subunit and leads to increased ribosomal biogenesis and ultimately 
increased protein synthesis [36, 37]. Studies on proliferative uterine myocytes throughout 
gestation indicate that upstream regulators, including IRS-1, PI3K, PKB and downstream 
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effectors S6K1 and 4EBP1 - which are all involved in activation of mTOR - were 
significantly up-regulated during the proliferative phase of myometrium differentiation 
[21]. mTORC1 pathway activation can be blocked by the m-TOR-specific inhibitor 
rapamycin [25]. When rapamycin was used to inhibit mTOR signaling in pregnant rats 
there was a reduction in the number of proliferating cells in the pregnant myometrium 
[21]. P-mTOR, P-S6K1 and P-4EBP1 protein expression decreased significantly in these 
rapamycin rats, supporting the notion that myometrial hyperplasia is controlled by the 
PI3K-PKB-mTOR signaling pathway [21]. 
1.3.2 The Synthetic Stage 
 At approximately d14 of gestation, proliferation decreases and it is followed by a 
synthetic phase in which myocyte growth switches to a phase of hypertrophic growth 
[38]. Hypertrophy refers to an increase in cell size and it is associated with an increase in 
the synthesis of extracellular matrix (ECM) and cellular growth [38, 39]. The cause of the 
switch in myocyte growth from proliferation to hypertrophy is unknown, but the switch 
coincides with the activation of the apoptotic cascade machinery [18]. There is significant 
up-regulation of specific caspases, such as initiator caspase-9 and effector caspases 3, 6 
and 7 at ~d14 of gestation, which are essential to apoptosis [18]. Even though the 
apoptotic cascade is activated during this window of time there are no physiological 
manifestations of myocyte apoptosis, indicating that it may be modulating other 
physiological processes [18]. Activation of the apoptotic pathway may be due to a period 
of hypoxia around mid-pregnancy in the rat that results from the growing fetus reaching a 
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maximal spherical radius and consequently, impeding maternal blood flow and oxygen 
supply [40]. Once the shape of fetal growth switches to ellipsoid, this relieves the tension 
and restores maternal blood flow throughout the uterus [40]. Evidence of myometrial 
hypoxia is shown by the presence of two different markers, hypoxia-inducible factor-1α 
and the hydroxyprobe pimonidazole hydrochloride, primarily in the circular muscle layer 
of the rat myometrium on d14 of gestation [41].   
 The synthetic phase of myometrial differentiation is characterized by an increase 
in the protein: DNA ratio in the pregnant rat myometrium, and a concomitant increase in 
the synthesis and deposition of interstitial matrix forming the ground substance of the 
myometrium [18]. The synthetic phase is also characterized by a marked increase in 
ECM proteins such as collagen I, collagen III and elastin, and reorganization of the ECM 
to ensure that cells are properly anchored throughout gestation [38, 42]. There is 
significant remodelling of cell matrix contacts through structures known as focal 
adhesions in cultured cells. 
 Focal adhesions are clusters of integrin molecules within the cell membrane that 
have extracellular domains that interact with the ECM surrounding the cell and 
cytoplasmic domains that interact with complexes of cytoplasmic and cytoskeletal 
proteins [43]. Extracellular ligands are coupled to cytoplasmic F-actin, by their integrin 
receptors, and thus mediate cell-matrix adhesions. The intracellular domain of integrin 
proteins interact with the cytoskeleton by adaptor proteins, such as talin, actinin and 
vinculin [44]. Focal adhesions are responsible for sensing mechanical forces and 
facilitating force transmittance generated through contractile proteins to the ECM and 
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muscle bundles [14, 43, 45].	   Two key players in the focal adhesion signaling network 
include focal adhesion kinase (FAK) and paxillin, as they have been associated with 
turnover and remodelling of focal adhesions. Focal adhesions may allow cells to maintain 
critical cell-matrix interactions as cells increase in size during the synthetic phase of 
myometrial programming, as phosphorylated (activated) FAK, or PTK2, is found in the 
gravid myometrium during the synthetic phase [46]. In the synthetic phase the expression 
of γ-smooth muscle actin and I-caldesmon also begin to increase, a finding characteristic 
of a relatively undifferentiated contractile state [47]. 	  
 Induction of myometrial hypertrophy requires an increase in uterine tension and 
the presence of progesterone. Progesterone appears to play a key role in pregnancy as it is 
required by almost all species for both the establishment and maintenance of pregnancy 
[48]. The circulating levels of progesterone in rat maternal serum have been found to 
peak specifically between d15-d19 after which there is a dramatic decline until labour 
[49]. Progesterone is known to suppress the initiation of labour as the removal of 
progesterone, via ovariectomy early in pregnancy or administration of a progesterone 
antagonist (mifepristone, RU486), results in early termination of pregnancy [50]. 
Administration of RU486 to pregnant animals on d17 resulted in attenuation of 
hypertrophy, thus indicating that progesterone circulation is essential for cell growth [19]. 
Progesterone is also important in the synthesis of ECM proteins, including collagen I and 
II and elastin. After progesterone levels decreased at term or following administration of 
RU486, the secretion of these proteins decreased significantly. Administration of RU486 
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also results in a premature increase in collagen IV, fibronectin and laminin expression 
[38]. In contrast, administration of exogenous progesterone at d23 delayed the onset of 
labour by reducing the level of fibronectin and laminin mRNA and preventing a decrease 
in collagen III mRNA [19, 38]. Fibronectin and laminin are ECM molecules that 
surround myometrial smooth muscle cells during the contractile stage [14, 38]. 
1.3.3 The Contractile Stage 
 At approximately d21 of pregnancy the myocytes differentiate further to a 
contractile phenotype, which lasts until d23 (labour). During this phase, hypertrophy is 
stabilized and there is a marked increase in the interaction between the myocyte and the 
underlying matrix. At this time, the myometrium becomes spontaneously active, 
excitable and highly responsive to uterine agonists [14]. Instead of synthesis of interstitial 
matrix, which is characteristic of the synthetic phenotype, there is significant up-
regulation of matrix proteins such as fibronectin, laminin β2 and collagen IV, which form 
the basement membrane surrounding each smooth muscle cell [14, 38]. This 
reorganization of uterine tissue architecture is crucial for extensive uterine hypertrophy 
[14]. In order to study the effects of stretch Ou et al. (1997) performed experiments in 
which virgin female rats underwent unilateral tubal ligation and therefore, the rat was 
only able to implant the conceptus in one horn [51]. This procedure provides an internal 
control allowing for separation of hormonal and mechanical influences. In unilaterally 
pregnant animals, the expression of matrix proteins (fibronectin, laminin β2 and collagen 
IV) was only found in the gravid horn, suggesting that uterine distension may be 
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regulating their expression [38]. Furthermore, increased expression of basement 
membrane proteins is associated with decreased levels of progesterone. Administration of 
RU486 to rats on d19 of gestation induced a switch from interstitial to basement 
membrane, as measured by the pre-mature increase in messenger ribonucleic acid 
(mRNA) levels of collagen IV, fibronectin and laminin, normally reached on day 23 
during labour [38]. In the reciprocal experiment, exogenous progesterone was 
administered to pregnant rats to prevent a normal drop in circulating hormone, it was able 
to block changes in matrix synthesis and the transition to the contractile phenotype [38].  
 The contractile phenotype is also characterized by changes in the expression of 
contractile protein isoforms within smooth muscle cells. There is a transition in the 
expression of α-smooth muscle actin to the γ-actin isoform, which is more characteristic 
of a contractile phenotype, in conjunction with the expression of smooth muscle-specific 
contractile forms of tropomyosin and myosin heavy chain [47]. Lastly, there is a notable 
increase in H-caldesmon expression, an actin binding protein that is capable of inhibiting 
actomyosin interaction in vitro [52, 53]. Li et al., performed immunostaining using a 
phospho-H-caldesmon antibody and noted that phospho- H- caldesmon increased ~40-
fold in staining during labour, compared to little staining of phospho-H- caldesmon in 
nonpregnant myometrium [53]. Thus, as H-caldesmon is involved in increasing smooth 
muscle contractility through thin filament mechanisms, caldesmon phosphorylation may 
reverse the inhibition of acotmyosin interactions by caldesmon which leads to increased 
contractility. [54, 55].  
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1.3.4 The Labour Phase 
 Just prior to d23 of gestation in the rat, the myometrium is activated and able to 
generate highly coordinated contractions that are capable of expelling the fetuses. This 
switch to an active state can occur as a result of signals produced by the maturing fetuses, 
including an up-regulation of corticotrophin-releasing hormone by the placenta, as well 
as an increase in mechanical stretch of the uterus [9]. At this point in gestation uterine 
growth is much slower than fetal growth, ultimately resulting in significant myometrial 
tension. Activation of the myometrium is defined biochemically as an increase in the 
expression of “contraction-associated proteins” (CAPs), such as the sodium channel, 
oxytocin receptor (OTR), prostaglandin F2α receptor and connexin 43 (Cx43; gap 
junction protein) and occurs as a result of the mechanical and endocrine signals [19, 50, 
56, 57]. Ou et al. (1998) determined through semi-quantitative reverse transcription-
polymerase chain reaction (RT-PCR) that OTR expression increases significantly with 
the onset of labour and thus oxytocin is able to stimulate uterine contractions [50]. 
Prostaglandin F2α (PGF2α) receptor is thought to play an important role in myometrial 
contractility as endogenous PGF2α is capable of inducing labour and administration of 
the cyclooxygenase inhibitor, indomethacin, is able to inhibit uterine contractions and the 
onset of labour [56, 57]. To further support the role of prostaglandin F (FP) receptors in 
uterine contractility, there was a significant increase in FP-receptor protein expression 
towards the end of gestation, with a marked increase at the onset of labour [58]. In 
unilaterally pregnant rats, the increase in CAPs is only found in the gravid horn, 
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consistent with the notion that stretch plays an important role in the labour-associated up-
regulation of these genes [50]. However, stretch is not the only requirement for 
expression of these genes as insertion of a polyvinyl tube into the non-gravid horn on d17 
of gestation, a time when the circulating levels of progesterone are high, did not result in 
an increase in CAP gene expression [19]. Therefore, the differentiation of the 
myometrium to the labour phenotype appears to require both mechanical and endocrine 
influences.  
 Stretch of uterine muscle has been found to induce transient myogenic 
contractions. In vitro studies on smooth muscle strips from rat uterus indicate that stretch 
of uterine muscle results in an intracellular influx of Ca2+, promoting stretch-induced 
contractions [59]. The increase in tension also results in an increase of CAPs, which 
results in activation of the myometrium and facilitates the coordinated contractions 
necessary for labour [5, 9].  Ou et al. (1997) found that an up-regulation of CAPs only 
occurred in the gravid (stretched) horns of unilaterally pregnant animals, which suggested 
that stretch had an important role in CAP activation [51]. Work performed by Shynlova 
et al. (2007) that focused on the same stretch model, further supported the role of uterine 
stretch on CAP activation as the artificially stretched horn showed higher OTR, Cx43, 
Cx26 and fibronectin expression in comparison to the non-gravid horn [14].  
Furthermore, Ca2+ influx and PKC translocation from the cytosolic compartment to the 
membrane compartment, as a result of EGF, induced phosphorylation of Cx43 [60]. 
Phosphorylation of connexins is important for proper formation and modulation of 
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function of gap junction channels. Thus, Ca2+ influx, as a result of mechanical distension, 
may regulate Cx43 phosphorylation in the cytoplasmic domain [61]. These experiments 
indicate the importance of uterine distension on activation of the myometrium via 
coordinated expression of CAPs [1, 14]. Through the use of the unilateral pregnant rat 
model, it is evident that mechanical stretch plays a key role in regulating the 
synchronous, high-amplitude, high frequency contractions at labour [62]. In addition to 
animal data, a study on primary cultures of human uterine smooth muscle cells, from 
pregnant women before labour, indicate that stretch results in up-regulation of OTR 
mRNA expression and increased OTR gene promoter activity [63]. Also, prostaglandin I2 
(PGI2), a potent vasodilator has been shown to be a major prostaglandin secreted before 
the onset of labour [64]. The effects of labour-like cyclic mechanical stretch on PGI2 
production has been analyzed in cultured human myometrial cells and the results suggest 
that cyclic mechanical stretch may be responsible for increased PGI2 concentration 
towards the end of gestation. More specifically, cyclic mechanical stretch up-regulated 
prostacyclin synthase (PGIS) expression, a synthase responsible for regulating 
biosynthesis of PGI2, via activation of the transcription factor activator-protein-1 (AP-1) 
[65]. 
 During labour, changes that must occur in the interaction between smooth 
muscles cells and the underlying matrix via focal adhesions. In screening rat myometrial 
stretch samples by anti-phosphotyrosine immunoblotting, Li et al. (2007) show an 
increase in the tyrosine phosphorylated bands identified as FAK, A- rapidly accelerated 
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fibrosarcoma (A-RAF), paxillin and Src in response to stretch [66]. MacPhee & Lye 
however, show a slightly different pattern of phosphorylated FAK expression [46]. 
Although tyrosine phosphorylation (P-Tyr) of myometrial FAK and its downstream 
substrate paxillin increase during late pregnancy (d15-d22), they found that there is a 
significant decrease in P-Tyr on d23 during the onset of labour [46]. Following 
administration of exogenous progesterone, pregnant animals show no decrease in FAK-P-
Tyr enzyme activity on d23 and consequently, the labour process is inhibited. These 
findings indicate that progesterone is involved in modulating FAK activity/focal adhesion 
signaling [46]. The fall in FAK-P-Tyr enzyme activity may allow for stabilization of 
smooth muscle cells and ECM interactions resulting in stable focal adhesions, connecting 
ECM and actin cytoskeleton via integrin molecules [14]. Together these results support 
the notion that focal adhesions are responsible for force transduction and modulation of 
myometrial contractility, ensuring that the myometrium works as a mechanical syncytium 
through each contraction [45]. 
1.3.5 The Involution Phase 
 Following fetal delivery the myometrium undergoes significant tissue remodelling 
as a result of induction of matrix metalloproteinases, ECM degradation, and cell 
apoptosis to return the tissue to the non-pregnant state [18]. This phase, known as the 
involution phase, completes the reproductive cycle following pregnancy. Following 
parturition there is an increase in IGF-I and IGFBP-5 gene expression and IGF-1R, the 
receptor that binds to both IGFs, which may be associated with uterine tissue recovery 
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[20]. Eighty five percent of the collagen of an involuting rat uterus is resorbed in the first 
four days following parturition, representing one of the fastest known rates of collagen 
degradation in any connective tissue [67]. Immune scavenging is an important component 
of myometrial remodelling enhanced by the expression of chemokines. Monocyte 
chemotactic protein-1 and other cytokines such as, monocyte chemotactic protein-3, 
eotaxin, fractalkine, and macrophage inflammatory protein -1β are required for 
postpartum decidual breakdown and myometrial involution [68].  
1.4 Regulation of Myometrial Contraction 
 Two different pathways initiate labour from fetal signals. One pathway is the fetal 
hypothalamic-pituitary-adrenal-placental axis and is primarily an endocrine cascade, 
whereas the other pathway is mechanical as the growing fetus creates tension on the 
uterine wall inducing changes within the uterine smooth muscle cells. As already 
described in section 1.3, it is thought that both of these pathways increase CAPs, as well 
as ECM proteins, cell matrix adhesion complexes, and contractile proteins to control the 
synchronized and temporally coordinated contractions of uterine myocytes at the onset of 
labour [43]. 
 Uterine smooth muscle cells are specialized cells that are packed with contractile 
myofilaments that are ready for contraction [12]. Excitability of uterine myocytes 
ultimately depends on the movement of Na+, Ca2+ and Cl- ions into the cytosolic 
compartment from the extracellular space, and of K+ ions into the extracellular space 
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from the cytosolic compartment. Intracellular Ca2+ concentrations ([Ca2+]i) increase due 
to Ca2+ entry via plasma membrane cation channels, as well as release from intracellular 
stores in the endoplasmic reticulum. Also, a number of myometrial contractants interact 
with a specific G-protein coupled receptor in the myocyte plasma membrane which 
activates a trimeric G-protein containing a Gαq subunit to increase [Ca2+]i [69]. Gαq 
activates phospholipase Cβ isoforms, causing the hydrolysis of phosphatidylinositide 
biphosphate (PIP2) to generate inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) 
[70]. IP3 binds to its receptors on the ER causing an increase in release of ER Ca2+ and a 
subsequent rise in [Ca2+]i [71, 72]. Similar downstream intermediates are also generated 
by an alternative pathway involving receptor tyrosine kinases that activate PLCϒ and 
generate IP3, ultimately increasing [Ca2+]i. [73]. Upon labour, contractant hormones can 
also indirectly cause depolarization of smooth muscle cell plasma membranes leading to 
the entry of extracellular Ca2+ into the myometrial cells via L-type voltage-gated Ca2+ 
channels, resulting in an increase in [Ca2+]i [74, 75]. When the membrane potential is 
depolarized to approximately −40 mV, the L-type voltage-gated Ca2+ channels open 
allowing a substantial influx of Ca2+ into the intracellular space [76]. Calmodulin, a 
calcium binding protein, requires binding of four calcium ions for its activation and thus 
a marked increase in Ca2+ is the key trigger for its activation [77]. The interaction 
between calcium and calmodulin then activates the key enzyme myosin light chain kinase 
(MLCK) by inducing a conformational change [1, 7]. Activation of MLCK results in 
phosphorylation of Ser19 on myosin light chains (MLC20) and causes a conformational 
change, ultimately increasing the angle in the neck domain of the two heavy chains of 
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myosin motor (MII) and the formation of a cross bridge between actin and myosin 
filaments (Figure 1.4). A marked increase in phosphorylation of MLC20 is important for 
activating the contractile machinery of the cell. MII undergoes a conformational change 
from the folded to extended state to become activated, allowing myosin and actin to 
move approximately 10 nm with respect to each other, resulting in a power stroke. 
Phosphorylation of the regulatory light chains of myosin also activates the myosin head 
domain, which constitutes the ATP hydrolysis site, to provide the mechanical energy 
required for contraction [17, 74]. Another mechanism of increasing the ATPase activity 
of MII is through phosphorylation of Thr18 on MLC20 [78-80].  
The force transmission between smooth muscle cells throughout the uterus may 
occur by conduction of action potentials through gap junctions [81]. Gap junctions are 
structurally differentiated areas of the plasma membrane of a cell that are composed of an 
array of small channels formed by proteins termed connexins [82]. Connexins are 
arranged into hexameric hemichannels, which become aligned across adjacent cells to 
form an interconnecting pore that permits electrical or ionic coupling between the cells 
and provides a pathway for small molecules to shuttle from one cell to another, directly 
linking the interior of adjacent cells [83]. Gap junctions allow electrical and metabolic 
coupling among cells as signals initiated in one cell can readily propagate to neighboring 
cells, thus allowing synchronous muscle contractions. Accordingly, during the last 12 
hours (h) of gestation in the rat, gap junctions between myometrial cells increase over 
200-fold creating an electrical syncytium allowing coordinated contraction 
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Figure 1.4 Steps involved in contraction of uterine smooth muscle. A marked increase in 
Ca2+ activates calmodulin, which then allows activation of the key enzyme MLCK by 
inducing a conformational change. Activation of MLCK results in phosphorylation of 
Ser19 on MLC20 and causes a conformational change; ultimately increasing the angle in 
the neck domain of the two heavy chains of myosin motor II (MII) and the formation of a 
cross bridge between actin and myosin filaments. MII undergoes a conformational 
change from the folded to extended state to become activated resulting in a power stroke 
and contraction. Based on figure from Wray, 1993 [75].  
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capable of delivering the fetus [81].  
 Following muscle contraction, in order to induce relaxation of the smooth muscle, 
Ca2+ must be removed from the cytosol. Relaxation occurs by several mechanisms, 
including actions of the plasma membrane (PMCA) and SR/ER (SERCA) Ca2+- ATPases 
and Na/Ca2+ exchangers, activation of K+ channels causing hyperpolarization of the cell 
and decreased voltage-mediated Ca2+ entry [17].  
1.5 Autophagy 
 During myometrial differentiation there is a period when the myometrium 
transitions from a state of hyperplasia to hypertrophy. This transition is associated with 
significant protein turnover. The main pathway for cells to degrade misfolded proteins is 
the ubiquitin-proteasome system. Recent evidence suggests that lysosomal degradation 
pathways (known as ‘autophagy’) also have essential roles in cellular protein quality 
control [84]. Autophagy or “self-eating”, is a ubiquitous and evolutionary conserved 
process and is found in yeast and mammals [85]. Three distinct types of autophagy have 
been described: macroautophagy, microautophagy and chaperone-mediated autophagy 
(CMA). Each autophagy type differs mechanistically from the others, but all types share 
a common role in degrading cytosolic components by lysosomal hydrolases (Figure 1.5) 
[86-88].  
 Macroautophagy refers to a multi-step process in which intact organelles and 
portions of the cytosol are initially sequestered into a phagophore or isolation membrane, 
a crescent shaped double membrane, that expands and fuses to form a double-membrane 
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vesicle known as an autophagosome. The isolation membranes are acquired from various 
intracellular membranes including the endoplasmic reticulum, Golgi apparatus, 
mitochondrial outer membrane and plasma membrane [89-92]. Subsequently, the 
autophagosome matures once the outer membrane of the autophagosome fuses with an 
endosome and/or lysosome, resulting in the formation of an 
autolysosome/autophagolysosome. The autolysosome results in the degradation of the 
luminal material, as well as the internal membrane. The resulting macromolecules are 
then released through membrane permeases and recycled in the cytosol [93]. More 
specifically, initiation of autophagosome formation requires the formation of a Unc-51-
like kinase (ULK) protein complex, which is composed of ULK1, autophagy-related gene 
(Atg)13, FIP200 and Atg101, along with other Atg proteins. mTOR–dependent and 
mTOR-independent pathways are the primary regulators of the assembly of the ULK 
protein complex [94]. mTOR-independent mechanisms alter the transcription of 
macroautophagy genes or they decrease the amount of 1,4,5-triphosphate [95, 96].  The 
next step involves nucleation and elongation of the isolation membranes to generate 
vesicular structures. Nucleation requires the assembly of the Beclin1/class III 
phosphatidylinositol 3-kinase (PI3K) complex [97, 98]. Elongation of the phagophore 
membrane is dependent on the Atg12 and microtubule associated protein light chain 3 
(LC3) conjugation system. A complex comprised of Atg5, Atg12 and Atg16L1 along 
with other autophagy-related genes regulate the conjugation of PE to LC3I to form 
LC3II, resulting in translocation of LC3 from the cytoplasm to the membrane of the pre-
autophagosomes [99-101]. Following nucleation and elongation, autophagosome 
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Figure 1.5 Scheme showing the relationship among the three known types of autophagy: 
Chaperone-Mediated Autophagy, Microautophagy and Macroautophagy. Adapted from 
Crotzer & Blum 2009 [88]. 
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undergo a process termed maturation in which they fuse with late endosomes and 
lysosomes for degradation of their contents [102, 103]. Maturation and degradation have 
been found to require late endosome marker protein Rab7 and lysosomal membrane 
protein LAMP-2 [104-106]. The constitutive or basal level of macroautophagy appears 
crucial for maintaining cellular homeostasis as it is responsible for the removal of 
damaged/old organelles, protein aggregates and the turnover of long-lived proteins. If 
cells encounter environmental stressors then the level of macroautophagy can increase 
significantly as a cytoprotective measure [107]. 
 Microautophagy involves direct sequestration of cytosolic components by 
invagination of the lysosomal membrane in the form of single-membrane vesicles [108]. 
A dynamin-related GTPase Vps1p regulates microautophagic invagination [109]. CMA is 
a selective lysosomal pathway that is responsible for degradation of single soluble 
cytosolic proteins that contain a pentapeptide lysosome-targeting motif, KFERQ. When 
the motif is exposed during protein misfolding or disassembly of protein complexes, it is 
recognized by heat-shock cognate (Hsc)70 and the cytosolic proteins are directly 
translocated into the lysosome after unfolding by a chaperone complex, comprised of 
Hsc70, Bcl2-associated athanogene (Bag)1, Hip, Hop and Hsp40/DNAJB1[110, 111]. In 
order for complete translocation into the lumen to occur the substrate proteins must bind 
to the cytosolic tail of LAMP-2A [112]. Binding of the substrate proteins to monomers of 
LAMP-2A stimulates its multimerization to form the approximately 700-kDa LAMP-2A 
complex necessary for substrate translocation [113]. The LAMP-2A complex is then 
disassembled into monomers in an Hsc70-dependent manner when substrates are no 
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longer available, thus initiating a new cycle of binding and translocation [113]. 
1.6 Small Heat Shock Proteins 
 Heat shock proteins (Hsps) have been found in Prokaryota and Eukaryota and are 
generally classified based on their molecular masses, properties and structures [114]. 
There are five classes of heat shock proteins: Hsp100, Hsp90, Hsp70, Hsp60 and the 
small heat shock proteins [115]. Heat shock proteins are known to act as molecular 
chaperones that block the aggregation of unfolded proteins and have a cytoprotective 
function under stressful situations [116]. The chaperone activities of Hsp100, Hsp90, 
Hsp70 and Hsp60 are regulated by the binding of ATP and subsequent hydrolysis; 
however, small heat shock proteins, in contrast to the major chaperones, show ATP-
independent chaperone-like activity [117]. 
  The human genome encodes ten different small heat shock proteins (sHsps) 
termed HspB1-HspB10 [118]. The sHsps form a ubiquitous family of molecular 
chaperones that have low molecular masses that normally range between 12 and 42 kDa 
[115]. This diverse family of proteins is characterized by a conserved C-terminal region 
consisting of 80-100 amino acids, termed the α-crystallin domain, a more variable N-
terminal sequence, and in most cases a short and variable C-terminal tail [119]. The α-
crystallin domain is often involved in the formation of dimers, whereas the N-terminal 
domain is involved in the formation of stable oligomeric complexes [115, 120-123]. The 
secondary structure of sHsps is a compact β-sheet sandwich composed of two layers of 
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three and five anti-parallel strands that are connected by a short interdomain loop [115, 
124].   
 sHsps are widely expressed chaperone proteins whose two main functions are to 
bind denatured proteins (in order to prevent stress-induced aggregation) and to maintain 
the solubility of denatured proteins until they can refold to their native conformation. 
sHsps are able to help promote the proper folding of these proteins, upon removal of the 
stress, by binding to exposed hydrophobic patches on protein substrates [125-127]. As 
sHsps exist in high molecular mass oligomers, substrate binding sites appear to 
correspond to temperature related exposure of hydrophobic interface sites, following 
dissociation of oligomeric complexes or an increase in subunit exchange between 
complexes [120, 128-130]. Unlike larger stress response chaperones, sHsps are ATP-
independent chaperones and are extremely important under stress conditions when the 
levels of ATP have been significantly depleted [116, 124, 126, 130, 131]. 
 One of the key features of sHsps is their ability to form large oligomeric 
complexes. sHsps may form complexes composed of 2-40 subunits that are either 
homomeric or heteromeric [118, 121, 130-134]. Oligomerization of sHsps is a dynamic 
process that becomes more rapid under stressful conditions [135-137]. The formation of 
oligomeric structures plays an important role in the chaperone functions of sHsps and 
may be a method of storage for inactive or partially active sHsps [126]. Oligomerization 
may also lead to the formation of several different homo- and hetero-oligomers, each 
with different binding properties to chaperone an extensive array of substrates [138-140]. 
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There are several known factors that result in the dissociation of sHsp oligomers 
including: temperature, ionic strength, pH, Ca2+ concentration, tissue age, or protein 
concentration [126, 128, 141-143]. One mechanism of sHsp activation is through 
temperature-dependent dissociation of oligomers [128-130]. Changes in the oligomeric 
organization of αB-crystallin increases the exposure of hydrophobic surface area and 
result in increased chaperone activity [144]. Regulating the exposure of hydrophobic 
surfaces through oligomeric organization may provide the molecular mechanism for sHsp 
regulation [144].  
Many sHsps undergo phosphorylation via various protein kinases and this may 
affect their chaperone activity. Most sHsps have phosphoralatable serine residues and 
phosphorylation has been found to modulate oligomerization and hence the function of 
these proteins within the cell [119, 145-152]. Phosphorylation affects sHsp cellular 
distribution [119, 153, 154]. 
 Expression of sHsp genes depends on the organism and the cell type. Some sHsp 
genes are ubiquitously expressed while others are only expressed in specific tissues. 
sHsps are often induced when cells and tissues respond to various stress signals 
including: heat, oxidative or osmotic stress, cold shock and heavy metals [126, 155-160]. 
These stress signals result in increased expression of sHsps through the binding of heat 
shock transcription factors (HSF1-4) to heat shock promoter elements, upstream of sHsp 
genes (Figure 1.6). Therefore there are two mechanisms to activate the Hsp response: 
detachment from oligomeric structures and novel transcription/translation.  
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Figure 1.6 Conditions that induce a heat shock response. Expression of sHsp genes 
depends specifically on the organism and the cell type; however, they are often induced 
when cells and tissues respond to various stress signals including: heat, oxidative or 
osmotic stress, cold shock and heavy metals. These stress signals result in an up-
regulation of sHsps through the binding of HSF-1 to heat shock promoter elements, 
upstream of sHsp genes, resulting in increased gene transcription of Hsps. Adapted from 
Hu et al., 2007 [160]. 
  
36 
 
 
 
 
 
 
  
Hsp$Promoter$ HSE$
Target$misfolded$$
proteins$
Misfolded$proteins$
Proapoptosis$
DNA$damage$
Enzyme$
denatura<on$
Signal$transduc<on$
Ac<ve$kinases$
ROS$
Temperature$
varia<on$
Amino$acid$$
analogues$
Oxygen$free$
radicals$
Transi<on$$heavy$$
metals$
Inhibitors$of$
energy$metabolism$
Inhibit$signals$event$$
in$the$apopto<c$
cascade$$
Decrease$
levels$$
of$ROS$
Hypertrophy$Par<cipate$in$vesicle$
fusion$and$
neurotransmission$
Refold$Prevent$
aggrega<on$of$
proteins$
Mediate$
degrada<on$of$
proteins$
Cell$cycle$
Growth$factors$
Development$and$
differen<a<on$
Oncogenes$and$
protoJoncogenes!
Fever$and$inflamma<on$
Neurohormonal$stress$
Hypertrophy$
Oxidant$injury$
Ischemia$
An<Jneoplas<c$
chemicals$
Viral$and$bacterial$
infec<on$
Neuronal$injury$
Tissue$injury$and$repair$
Aging$
pH$extremes$
Osmo<c$changes$
Gene$Transcrip<ons$
Phosphoryla<on$&$$
Nuclear$Transloca<on$
$HSFJ1$ Trimeriza<on$&$Binding$
P! P! P!
$HSFJ1$HSFJ1
$HSFJ1$
37 
 
1.7 HspB8 Protein 
HspB8 (also known as Hsp22, H11 and E2IG1) possesses the structural motif of 
the alpha-crystallin family of Hsps and is considered to be a member of the superfamily 
of sHsps [118, 160, 161]. HspB8 has a very low molecular mass of approximately 21.6 
kDa and consists of 196 amino acids [162]. HspB8 protein is predominantly expressed in 
skeletal and smooth muscles, heart and brain, with moderate expression in cervix, 
prostate, lung, kidneys, heart, placenta and spleen [132, 162]. HspB8 has been found to 
possess two putative HSF1 binding sites (HSEs) 1000 bases upstream of the translation 
start site, suggesting that it may be stress-inducible [132]. 
The secondary structure of HspB8 is randomly coiled, and in vitro is monomeric. 
According to Kim et al. (2004) 36 % of human HspB8 is β-structured, 5 % is alpha 
helices and about 58 % is comprised of turns and unordered structures [163]. HspB8 also 
lacks the β2 strand detected in many sHsps [164, 165]. Thus, HspB8 is a member of the 
group of intrinsically disordered proteins, which are known to play vital roles in 
recognition, regulation and cell signaling [166]. The aromatic amino acids of HspB8 are 
in a chiral environment that is comparable with those of αβ-crystallin and the sequence of 
HspB8 includes three cysteine residues, but no disulphide bonds [132]. HspB8 is resistant 
to thermal denaturation but highly susceptible to proteolysis [164, 165, 167].  
 HspB8, like other intrinsically disordered proteins is phosphorylated by several 
protein kinases. In vitro, protein kinase C phosphorylates Ser14 and Thr63, ERK1 
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phosphorylates Ser27 and Thr87 whereas casein kinase 2 phosphorylates a number of 
unidentified sites [162]. HspB8 is also phosphorylated by cAMP-dependent protein 
kinase at Ser24 and Ser57 in vitro; however, Ser57 is the primary site of phosphorylation 
[148]. Phosphorylation by cAMP-dependent protein kinase affects the structure and 
decreases the chaperone-like activity of HspB8 in vitro [148]. HspB8 is phosphorylated 
at Ser24 and Ser(Thr)87 in vivo [168-170]. Furthermore, HspB8 is phosphorylated at 
Tyr118 in non-small-cell lung cancer cells [171]. Despite this information, the effect of 
phosphorylation on the structure and properties of HspB8 has yet to be fully examined.  
Although HspB8 is highly expressed in muscle, its exact function remains 
unclear. Originally HspB8 was reported to have protein kinase activity but the evidence 
has been inconsistent [172, 173] HspB8 protein kinase activity was analyzed using SDS-
gel electrophoresis with alpha-casein and histone IIIS as the protein substrates [163]. The 
authors found that HspB8 was not capable of phosphorylating alpha-casein or histone 
IIIS; however, the substrates were phosphorylated by purified rat liver casein kinase II 
and by the catalytic subunit of cAMP- dependent protein kinase, respectively [163]. 
Furthermore, HspB8 only contains seven out of eleven motifs that are typically 
characteristic of protein kinases, indicating only weak similarity between the primary 
structure of HspB8 and protein kinase motifs [174]. Kim et al. (2004) attribute the 
previous protein kinase activity to protein kinases tightly bound to HspB8, as a result of 
sample contamination [163].  
HspB8 has chaperone-like activity, similar to many other sHsps. It prevents 
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aggregation of partially unfolded or denatured proteins in vivo [132, 167, 175]. Heating 
results in aggregation of yeast alcohol dehydrogenase (ADH), particularly in the presence 
of reducing agents. Upon addition of HspB8 to ADH there was decreased aggregation 
[163]. A similar result was obtained when bovine liver rhodanese was used as a substrate. 
Thus, HspB8 was capable of preventing heat-induced aggregation of both ADH and 
bovine liver rhodanese, indicating chaperone activity similar to HspB6 [163]. HspB8 also 
prevents the formation of amyloid oligomers and aggresomes formed by the R120G 
mutant of αβ-crystallin, which causes desmin-related cardiomyopathy [176, 177]. 
Overexpression of HspB8 was accompanied by improved cardiac function and survival 
[176]. Furthermore, HspB8 was more effective than HspB1 and αβ-crystallin in 
preventing in vivo aggregation of polyglutamine containing proteins (polyglutamine 
protein Htt43Q and androgen receptor containing 65 glutamine residues). HspB8 also 
maintains Htt43Q in a soluble state allowing for its rapid degradation [178]. Together 
these results demonstrate that HspB8 has chaperone-like activity.  
 sHsps are able to interact with each other to form homo- and hetero-oligomeric 
complexes and suggesting that the formation of these complexes is essential for their 
function [123]. The conserved alpha-crystallin domain is involved in the formation of 
both homo- and hetero- dimers. HspB8 has at least two binding sites that permit 
interaction with itself, HspB7, myotonic dystrophy protein kinase binding protein, 
HspB1, αβ-crystallin and HspB6 [179]. 
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 HspB8 can form homo-dimers, which can subsequently dimerize to form 
tetramers [180]. Yeast tyrosine hydroxylase assays were performed to determine whether 
or not HspB8 was able to interact with itself. Both of the reporter genes (his+, gal+) 
indicated the presence of HspB8 dimers [180]. Size exclusion chromatography and 
chemical cross-linking with dimethylsuberimidate, were performed by Kim et al. (2004) 
and they also found that HspB8 is capable of forming stable dimers [163]. When HspB8 
was incubated with increasing quantities of β- mercaptoethanol there was decreased 
intensity of the putative HspB8 band on immunoblots analogous to an HspB8 dimer 
(~40-45 kDa) and increased intensity of an HspB8 band corresponding to the monomeric 
form of HspB8 (22 kDa). There was also evidence of high molecular mass complexes on 
the top of the gel. Therefore, it was proposed that HspB8 is capable of forming disulfide 
cross-linked dimers, as well as unordered crosslinked oligomers having high molecular 
mass [163]. Following oxidation both the secondary and tertiary structures of HspB8 are 
disrupted, which affects the formation of intermolecular disulfide bonds and thus cross-
linked dimers. To examine the formation of homo-oligomeric complexes Sun et al. 
transfected 293T cells to express FLAG-tagged HspB8 that was treated with different 
concentrations of glutaraldehyde, allowing cross-linking of cell proteins [180]. Bands 
were observed at ~30, 65 and 120 kDa, however, with increased glutaraldehyde 
concentration a band was observed having a molecular mass of 250 kDa [180]. This data 
indicated that HspB8 formed homo-dimers, as well as homo-oligomers [163, 180]. 
 Significant sequence similarity exists between HspB8 and HspB1, which may 
account for their interaction. Human HspB1 has three sites of serine phosphorylation 
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including Ser15, Ser78 and Ser82 [180]. Originally, Benndorf et al. (2001) showed an 
interaction between HspB8 and a mimic of phosphorylated HspB1 (a triple aspartate 
mutant) [162]. However, in recent studies it has been shown that HspB8 weakly interacts 
with HspB1 without the need for HspB1 phosphorylation [180, 181]. The interaction 
between HspB8 and HspB1 involves the C-terminus of HspB1, which must interact with 
full-length HspB8 [179, 180, 182]. Although it is thought that hetero-oligomeric 
complexes are crucial for function, the significance of this interaction is still undefined. 
 Most recently, HspB8 has been found to interact with the adapter protein Bag3, a 
known stimulator of macroautophagy, in human cervical cancer (HeLa) and African 
green monkey kidney (COS-1) cells [183]. Currently there are two proposed methods for 
stimulation of macroautophagy via an HspB8-Bag3 complex. First, HspB8 is part of a 
multiheteromeric complex comprised of HspB8, Bag3, Hsc70 and C-terminus of Hsc70-
interacting protein (CHIP). This complex is then responsible for the removal of misfolded 
proteins through macroautophagy activation [184]. However, there is also evidence that 
HspB8 and Bag3 are working independently of Hsc70 and CHIP to promote 
phosphorylation of the α subunit of translation initiator factor eIF2 and stimulation of 
macroautophagy [185, 186].  
 
1.8 Bag Proteins  
 The human genome encodes six different members of Bag proteins including 
Bag1 (and its various isoforms), Bag2, Bag3 (CAIR-1; Bis), Bag4 (SODD), Bag5 and 
Bag6 (Scythe, BAT3) [187]. The Bag proteins are a family of co-chaperones, which are 
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capable of interacting with the ATPase domain of Hsc70/Hsp70 through their structural 
Bag domain (110-124 residues) [188, 189]. The Bag domain is an evolutionary conserved 
domain consisting of ~110 amino acids and three anti-parallel alpha-helices, each ~30-40 
amino acids in length [190]. The first and second helices interact with the 
serine/threonine kinase RAF-1 and the second and third helices are the sites of the BAG 
domain interaction with the ATPase domain of Hsc70/Hsp70 [190, 191]. The interaction 
between the Bag domain and the ATPase domain of Hsp/Hsc70 is reported to regulate the 
ATP-driven activity of the chaperone complex [192]. All members of this family contain 
one Bag domain, which is located in the C-terminal portion of the molecule, except Bag5, 
which contains five putative Bag domains [188, 190]. The N-terminal regions of the 
family members vary in both length and composition [188, 190]. 
Bag1 has several isoforms which interact with several molecular targets including 
Bcl2 apoptosis regulator, constitutively expressed Hsc70, heat-inducible Hsp70, nuclear 
hormone receptors, the RAF-1 kinase, components of the proteasome machinery and 
DNA [191, 193, 194]. Bag1, along with its binding partners, is involved in diverse 
cellular functions [195, 196]. Bag1 has been found to serve as an anti-apoptotic molecule 
by suppressing apoptosis upstream of caspase activation and thus, is involved in cell 
survival and proliferation [197, 198]. Another key role of Bag1 is to mediate protein 
quality control by targeting selected proteins for proteasome-mediated degradation [199]. 
Bag1 binds to Hsc/Hsp70 via its carboxy-terminal BAG domain and associates with the 
proteasome in an ATP-dependent manner, promoting binding of Hsc70 and Hsp70 to the 
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proteolytic complex [189]. Bag1 is considered a coupling factor between the Hsp70 
chaperone system and the proteolytic complex. Bag1 and Bag3, however, appear to be 
reciprocally regulated during cellular aging and under acute oxidative or proteasomal 
stress (Figure 1.7) [200, 201]. Bag1 maintains protein quality control through Bag1-
dependent proteasomal degradation of polyubiquinated proteins, mediated by the Hsp70 
chaperone system. However, when there is an accumulation of misfolded proteins and a 
decrease in the efficiency of proteasomal degradation, there is an up-regulation of Bag3-
mediated macroautophagy. This is referred to as a Bag1/Bag3 “switch” and is thought to 
be a physiological adaptation to the changing protein degradation demand during cellular 
aging and proteasomal stress [183, 184, 200, 202].  
 Bag 3 is another member of the Bag family co-chaperones and, in addition to the 
Bag domain, it possesses a tryptophan domain (WW) at its N-terminus and a proline-rich 
repeat (PXXP) at its central region [183]. The WW domain is a protein-protein 
interaction domain that has been found to bind to proline-rich ligands, including the 
adenovirus penton base protein and the PDZ domain containing guanine nucleotide-
exchange factor 2 [203, 204]. The only known protein to interact with the Bag3 proline-
rich region is Phospholipase C-gamma 1 (PLCγ-1), an SH3 containing protein involved 
in growth signal transduction [187, 205]. PLCγ-1 interacts with γ-tubulin and modulates 
the assembly of microtubules, which are essential for macroautophagy [206, 207]. The 
BAG domain of Bag3 is required for its interaction with Hsp70/Hsc70 and Bcl2, an anti- 
 
44 
 
 
 
 
 
 
 
Figure 1.7 The Bag1 to Bag3 switch. In order to maintain protein homeostasis in times of 
proteasomal stress there is an increase in the Bag3/Bag1 ratio, resulting in the recruitment 
of the macroautophagy pathway. The Bag1/Bag3 switch is thought to be a physiological 
adaptation to the changing protein degradation demand during cellular aging and 
proteasomal stress. Adapted from Behl, 2011 [201].   
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apoptotic protein [187]. Hsp70/Hsc70 subsequently interacts with co-chaperones such as 
CHIP, an E3 ligase [208]. Bag3 is the only member of this family that can be induced by 
stressful stimuli, as a result of HSF1 binding to heat shock-responsive elements on the 
Bag3 gene promoter [209]. It is known that the full-length product of the Bag3 gene has 
an apparent mass of 74 kDa and is localized to the cytoplasm, however another form of 
Bag3 has also been described [188]. The shorter form of Bag3 (~40 kDa) has been 
characterized by immunoprecipitation and mass spectrometry in neural synaptosome 
homogenates yet it is unclear whether this form is due to alternative splicing or 
proteolytic processing [210].  
 According to Fuchs et al. (2010) two conserved Ile-Pro-Val (IPV) motifs in Bag3, 
located between the WW domain and the proline-rich domain, are crucial for mediating 
binding to HspB8 [211]. Furthermore, HspB8 binds to Bag3 through its hydrophobic 
groove, formed by β4 and β8 strands (Figure 1.8A). A filter-trap assay also determined 
that the HspB8-Bag3 complex is capable of stimulating the clearance of aggregation-
prone Htt43Q (Huntingtin exon 1 fragment with 43 CAG repeats) through stimulation of 
the macroautophagy pathway (Figure 1.8B) [211, 212]. 
 The multichaperone complex (Bag3-HspB8-Hsp70/Hsc70) is thought to mediate 
macroautophagy in cooperation with the macroautophagy receptor protein p62/SQSTM1 
(sequestome 1). This protein is known to be a stress-regulated multi-adaptor protein that 
is capable of binding to ubiquitin and microtubule associated protein light chain 3 II 
(LC3II), the autophagosome membrane-associated protein, simultaneously [213]. p62 
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Figure 1.8 (A) The current model of sHsp structure. In the ribbon diagram of the 
Triticum Aestivum Hsp16.9 monomer N and C indicate the N- and C-terminal domains 
respectively. The amino acid residues that form the hydrophobic groove are shown as 
blue balls on β4 and as red balls on β8. The hydrophobic groove of HspB8 is crucial for 
the interaction between HspB8 and Bag3. Reproduced from Fuchs et al., 2010 [215]. (B) 
Two conserved Ile-Pro-Val (IPV) motifs in Bag 3, located between the WW domain and 
the proline-rich domain, are crucial for mediating binding to HspB8. The HspB8-Bag3 
complex is capable of stimulating the clearance of aggregation-prone Htt43Q protein 
through Bag3-mediated macroautophagy stimulation. Based on figure from McCollum et 
al., 2010 [212]. 
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binds directly to LC3II by its LIR motif (LC3-interacting region), an 11-amino acid long 
linear motif [214, 215]. LC3II has been found to exist on autophagosomes and therefore 
it is often used as a marker for autophagosome accumulation [216, 217]. Nascent LC3 is 
initially processed at its C-terminus by autophagy-related protein (Atg) 4 and becomes 
LC3I, which possesses a glycine residue at its C-terminal end. LC3I is subsequently 
conjugated with phosphatidlyethanolamine, via an ubiquination-like enzymatic reaction, 
to form LC3II. LC3I is known to have cytoplasmic localization, whereas LC3II is 
associated with the outer and inner membranes of the autophagosome [218]. Following 
self-oligomerization of p62/SQSTM1, it is able to sequestrate ubiquinated substrates in 
the form of inclusion bodies, which are then engulfed by the autophagosome membrane 
through recruitment of LC3II [213].  
 Furthermore, Bag3-HspB8-Hsp70/Hsc70 and CHIP bind to mutated superoxide 
dismutase 1 (SOD1) and then target it for degradation through macroautophagy 
stimulation [184]. CHIP serves as a cochaperone, as well as an ubiquitin ligase and it is 
highly expressed in the heart, vascular cells and other cells [219]. CHIP, in possessing E3 
ubiquitin ligase activity, is able to ubiquinate target proteins [220]. Thus, this 
multichaperone complex may ubiquinate-chaperoned substrates and then target them for 
degradation by p62/SQSTM1 and activation of the macroautophagy pathway (Figure 1.9) 
[202, 208, 221].  
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Figure 1.9 HspB8 and the macroautophagy pathway. HspB8 in, interacting with Bag3, is 
part of a multiheteromeric complex comprised of HspB8, Bag3, Hsp70/Hsc70 and CHIP. 
HspB8 is responsible for recognizing the misfolded proteins and subsequently the 
multichaperone complex mediates macroautophagy in cooperation with the 
macroautophagy receptor protein p62. CHIP ubiquinates target proteins and p62 is then 
capable of binding to ubiquitin and LC3II, the autophagosome membrane-associated 
protein, simultaneously. Thus, this multichaperone complex may ubiquinate-chaperoned 
substrates and then target them for degradation by p62 and activation of the 
macroautophagy pathway. Based on figure from Carra et al., 2009 and Mymrikov et al., 
2011 [186, 221]. 
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1.9 Study Rationale and Hypotheses 
 Due to a preliminary immunoblot result in the MacPhee laboratory, which 
indicated that HspB8 may be expressed in the rat myometrium during gestation, the first 
hypothesis for this study was that HspB8 protein expression in rat myometrium will be 
elevated towards mid-gestation coincident with myometrial hypertrophy, as a means to 
regulate protein homeostasis. Throughout the stages of myometrial differentiation the 
myometrium transitions from a state of hyperplasia to hypertrophy. This transition is 
associated with significant protein turnover; thus, the second hypothesis is that HspB8, 
Bag3 and other members of a regulatory pathway, such as macroautophagy, should be 
expressed in the myometrium at this time to help maintain protein homeostasis.  
 To address these two major hypotheses I set out two main goals for this thesis 
project. The first goal was to characterize the expression of HspB8 protein and potentially 
associated autophagy machinery in the rat myometrium during pregnancy compatible 
with a functional significance for the HspB8 protein in myometrial hypertrophy. The 
second goal was to characterize the potential regulation of HspB8 protein expression in 
pregnant rat myometrium during pregnancy as the uterus changes from a quiescent tissue 
to a contractile tissue. In order to achieve these goals, four main experimental objectives 
were proposed: 
 
Objective 1: To determine the spatial and temporal localization of HspB8 protein 
in the rat myometrium throughout pregnancy and labour. 
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Objective 2: To determine whether mechanical stretch, progesterone or a 
functional progesterone withdrawal (RU486) affects HspB8 protein expression in 
the rat myometrium.  
Objective 3: To characterize the expression of proteins associated with HspB8 in 
the process of hypertrophy including: Bag3, Bag1, Hsp70, Hsc70, CHIP, LC3II, 
eIF2α and γ-actin. 
Objective 4: To determine whether HspB8 and Bag3 form a complex during 
myometrial programming, particularly during the synthetic phase. 
Some experiments used uterine tissue lysates and tissue sections which were 
collected by other students in the MacPhee laboratory including: Bryan White, Brandon 
Cross, Joy Williams and Mandy Peach. However, I collected additional samples 
throughout the duration of this thesis project and all experimental findings described in 
this thesis are the result of my own personal work in the laboratory.  
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Chapter Two 
Materials and Methods 
2.1 Animals 
 Sprague Dawley rats were acquired from Mount Scio Vivarium (Memorial 
University of Newfoundland, St. John’s, NL, Canada) and used for all experiments. The 
rats were kept under the supervision of the Animal Care Unit at the Health Sciences 
Centre, Memorial University of Newfoundland and housed under standard environmental 
conditions of 12 h of light and 12 h of darkness. The rats had access to tap water ad 
libitum and were maintained on LabDiet Prolab RMH 3000 (PMI Nutrition International, 
Brentwood, MO, USA). For all experiments, virgin female rats weighing approximately 
220-250 grams were mated with male rats. D1 of the gestational period was designated 
following the observation of a vaginal plug the morning after mating. The time of 
delivery under these standard conditions was d23 of the gestational period. All 
experiments were granted ethical approval by the institutional animal care committee 
under protocols 08-02-DM to 11-02-DM. 
2.2 Experimental Design 
2.2.1 Tissue Collection 
 Each animal was placed in a euthanasia chamber and exposed to increasing 
concentrations of carbon dioxide, resulting in death by asphyxiation within 5-10 minutes 
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(min). Uterine horns were then removed, excised and opened longitudinally, after which 
fetuses and placentae were discarded. Uterine tissue was then placed in ice cold 
phosphate-buffered saline (PBS; pH 7.4) and a scalpel blade was used to gently scrape 
away the endometrial layer [222-224]. All myometrial samples were flash-frozen in 
liquid nitrogen and stored at -80oC. Each set of myometrial samples was composed of 
samples from ten time points throughout gestation including: non-pregnant (NP), d6, d12, 
d15, d17, d19, d21, d22, d23 (labour) and 1 day post-partum (PP). NP samples were not 
standardized to a given time of day or day in the ovarian cycle. Labour samples were 
collected during active labour, following the delivery of 2-3 pups [222-225]. For 
immunofluorescence detection a portion of rat uterine horn was fixed in 4 % 
paraformaldehyde (PFA) in PBS (pH 7.4) while shaking overnight at room temperature 
(RT). Tissues were processed, paraffin embedded, sectioned and mounted on microscope 
slides by the Histology Unit of Memorial University of Newfoundland School of 
Medicine. Cross sections of the uterine horn were used for immunofluorescence 
experiments and both the longitudinal and circular muscle layers of the myometrium 
were included in all sections. For each experiment all sections were treated at the same 
time under identical conditions.  
2.2.2 Unilateral Pregnancy Model 
 Tissue samples from a unilateral pregnancy model were collected by Dr. Bryan 
White. Detailed procedures of tissue acquisition for this model are reported elsewhere 
[223]. Briefly, virgin female rats underwent general anesthesia followed by unilateral 
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tubal ligation through a flank incision so the rats were only able to become pregnant in 
one horn [223]. Animals were allowed a 7-day period after which the females were mated 
with male rats. The tissue samples were collected from both non-gravid (NG; empty) and 
gravid uterine horns on d15, d19 and d23 (n=4/day) of gestation. Labour samples (d23) 
were collected during active labour, following the delivery of 2-3 pups. 
2.2.3 Progesterone-delayed Labour 
 The levels of serum progesterone peak between d15-d19, after which there is a 
dramatic decline leading into labour [49]. In order to investigate progesterone regulation 
of HspB8 protein expression, pregnant rats were given either a daily injection of 
progesterone (4 mg subcutaneously (s.c) in 0.2 mL of corn oil) to maintain elevated 
plasma levels of progesterone, or vehicle alone (0.2 mL of corn oil s.c.) beginning on d20 
of gestation. Samples were collected from animals receiving injections of vehicle alone 
on d21, d22 and d23 (during labour), whereas samples from the progesterone-treated rats 
were collected on d21, d22 and d23; however, on d23 the rats were not in labour 
(n=4/day). 
2.2.4 RU486-induced Progesterone Withdrawal 
 RU486 (Mifepristone) is a 19-norsteroid that blocks the action of the hormone 
progesterone, which is crucial for initiating and maintaining pregnancy [226]. Therefore, 
upon administration of RU486 to pregnant rats on d18 of gestation, preterm labour is 
induced within 24 h. On d18 of gestation two groups of rats were treated with either 
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RU486 (10 mg/kg, s.c, in 0.5 mL of corn oil containing 10 % ethanol, Mifepristone; 17β-
hydroxy-11β-[4-dimethylaminophenyl]-17-[1-propynyl]-estra-4, 10-dien-3-one; (Sigma-
Aldrich, St. Louis, MO, USA) or vehicle alone (0.5 mL of corn oil). Myometrial samples 
were collected from both treatment groups on d19 of gestation. RU486 treated rats were 
killed during active labour, following the delivery of 2-3 pups (n=4/day). 
2.3 Immunoblot Analysis 
 Immunoblot analysis was performed for gestational profiles of protein expression 
as well as for stretch, progesterone, RU486 and IP experiments. Four independent sets of 
protein samples (n=4/day; i.e. 4 rats used per gestational time point) were used for all 
studies. Sample sizes of n=4/day are routinely used for immunoblot analysis within the 
field [14, 18, 45]. Frozen rat myometrial samples were pulverized under liquid nitrogen 
and homogenized with a Bead Mill (PreCellys, Markham, ON, Canada) in 
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCL (pH 7.5), 150 mM 
NaCl, 1 % (vol/vol) Triton X-100, 1 % (wt/vol) sodium deoxycholate, and 0.1 % (wt/vol) 
sodium dodecyl sulfate (SDS)) containing Phosphatase Inhibitor Cocktail and 
CompleteTM Mini Ethylenediaminetetraacetic acid (EDTA)-free protease inhibitors 
(Roche Molecular Biochemicals, Laval, QC, Canada). Samples were centrifuged for 15 
min at 15000 x g at 4 °C and supernatants collected. Protein concentrations of each 
sample were obtained using the Bradford Assay (Bradford, 1976). The Bradford Assay 
involves deducing the concentration of a protein sample from its spectrophotometric 
absorbance (A595) when compared to a standard curve of A595 readings of protein 
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standards of known concentrations. A duplicate set of 7 protein standards (0, 2.5, 5, 10, 
15, 20, 25 mg/ml) were prepared using bovine serum albumin (BSA) diluted in double 
deionized water (ddH2O). One mL of 1X Bio-Rad protein assay dye reagent (Bio-Rad 
Laboratories, Mississauga, ON, Canada) was added to each sample and the absorbance 
was measured at 595 nm with a Shimadzu BioMini spectrophotometer. Samples for 
protein determination were prepared using a similar method. One µL of each protein 
lysate, of unknown concentration, was combined with 24 µL of ddH2O and 1 mL of 1X 
Bio-Rad protein assay dye reagent. All samples were prepared in duplicate. The 
absorbance was measured at 595 nm and compared to the standard curve. Standard 
protein determinations were made according to the manufacturer's instructions (BioRad). 
Myometrial protein samples (40 µg/lane) were then separated by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) in 10 %, 12 % or 15 % resolving gels, according to 
Laemmli [227], and proteins were electroblotted to 0.2 µm nitrocellulose membranes 
(BioRad, Mississauga, ON, Canada). A MemCode™ Reversible Protein Stain Kit was 
always used, according to the manufacturer’s instructions, for detection of proteins on 
nitrocellulose membranes to confirm the efficiency and relative homogeneity of protein 
transfer in each lane. 
 After protein transfer, membranes were washed with Tris-buffered saline-Tween-
20 (TBST; 20 mM Tris base, 137 mM NaCl, and 0.1% Tween-20; pH 7.6) followed by a 
1 h block in 5 % milk powder/TBST or 5 % BSA/TBST, depending on antisera 
specifications, in order to prevent any non-specific binding of antibodies. Membranes 
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were probed with appropriate primary antisera (Table 2.1) and then washes (1X 20 min 
and 4X 5 min) were performed with TBST and constant shaking. Following primary 
antibody incubation, blots were probed with the appropriate secondary antisera (Table 
2.2) and washes (1X 20 min and 4X 5 min) were repeated with TBST and constant 
shaking at RT. Protein detection was initiated by incubating the blot for 1 min in the 
Pierce SuperSignal West Pico chemiluminescent substrate detection system (MJS 
Biolynx, Inc., Brockville, Ontario, Canada). Multiple exposures of varying time lengths 
were conducted on Amersham ECL film (GE Healthcare Limited, Little Chalfont, BKM, 
UK) to ensure the film response was in the linear range and then the film was developed 
in an automated X-ray film developer. Calponin protein expression was used as a 
normalization control for rat myometrial tissue lysates, following probing with antisera 
raised against the protein of interest, as this protein is constitutively expressed in both 
pregnant and non-pregnant rat myometrial samples following RIPA lysis buffer protein 
extraction [45, 222]. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) protein 
expression was used as normalization control for cell lysates, as it is stably and 
constitutively expressed at high levels in most tissues and cells [228]. 
2.4 Immunofluorescence Detection 
 Slide-mounted tissue sections were de-waxed and rehydrated in a graded series of 
xylene (3X 100 % for 5 min each) and ethanol washes (1X 100 %, 95 %, 90 %, 80 %, 70 
% and 50 % for 3 min each). Following rehydration, slides were washed in PBS (3X 7  
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Table 2.1 List of primary antibodies used for this study. 
IF, immunofluorescence; IB, immunoblot; *Dependent on the concentration of the primary antisera used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Antisera Antibody type Method Dilution Incubation Catalogue Number 
 
Bag1 Mouse monoclonal IB 1:1000 1 hr RT LS-C95531 
Lifespan Biosciences, WA, USA 
Bag 3 Mouse monoclonal IB 1:1000 2 hrs RT ALX-803-323 
Enzo Life Science, NY, USA 
Bag 3 Rabbit polyclonal IB 1:10 000 1 hr RT Generous gift from Dr. Jacques 
Landry Laboratory 
Bag 3 Rabbit polyclonal IF 1:100 Overnight 
at 4oC 
Generous gift from Dr. Jacques 
Landry Laboratory 
CHIP (STUB1) Rabbit monoclonal IB 1:1000 1 hr RT LS-C137950 
Lifespan Biosciences, WA, USA 
ChromPure 
rabbit IgG 
N/A IF N/A* N/A 011–000–003 
Jackson ImmunoResearch 
Laboratories, PA, USA 
γ-actin Sheep polyclonal IB 1:2000 1 hr RT AB3265 
Millipore, MA, USA 
GAPDH Rabbit polyclonal IB 1:5000 I hr RT Ab9485 
Abcam Inc., Cambridge, MA, USA 
HspB8 Rabbit polyclonal IB 1:1000 2 hrs RT LS-C81990 
Lifespan Biosciences, WA, USA 
HspB8 Rabbit polyclonal IF 1:400 Overnight at 
4oC 
LS-C81990 
Lifespan Biosciences, WA, USA 
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Table 2.1 (cont.) List of primary antibodies used for this study. 
 
IB, immunoblot; RT, room temperature 
 Antisera Antibody type Method Dilution Incubation Catalogue Number 
HspB8 Rabbit polyclonal IB 1:1000 2 hrs RT #3059 
Cell signalling, ON, CA 
HspB8 Rabbit polyclonal IB 1:1000 1 hr RT Generous gift from Dr. Jacques 
Landry Laboratory 
Hsc70 Rabbit polyclonal IB 1:1000 2 hrs RT ADI-SPA-816 
Enzo Life Sciences, NY, USA 
Hsc70 Rabbit polyclonal IB 1:1000 1 hr RT SPC-102C/D 
StressMarq, BC, CA 
Hsp70 Mouse monoclonal IB 1:1000 2 hrs RT ADI-SPA-810 
Enzo Life Sciences, NY, USA 
LC3II Rabbit polyclonal IB 1:1000 2 hrs RT PA1-46286 
Thermo Scientific, IL, USA 
Myc-tag Rabbit polyclonal IB 1:1000 1 hr RT 06-549 
Millipore, MA, USA 
Phospho-EIF2α 
(Pser51) 
Rabbit polyclonal IB 1:1000 2 hrs RT SAB4300221 
Sigma-Aldrich, MO, USA 
Smooth muscle 
calponin 
Mouse monoclonal IB 1:100 000 1 hr RT C2687 
Sigma-Aldrich, St. Louis, MO, USA 
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Table 2.2 List of secondary antibodies used for this study. 
 
IB, immunoblot; IF, immunofluorescence; IP, immunoprecipitation; FITC, fluorescein isothiocyanate; HRP, horseradish peroxidase; 
RT, room temperature. 
	  
Antisera Antibody type Method Dilution Incubation Catalogue Number 
 
HRP-conjugated 
goat anti-rabbit 
IgG 
Goat polyclonal IB 1:10 000 1 hr RT W401B 
Promega, Madison,WI, USA 
HRP-conjugated 
goat anti-mouse 
IgG 
Goat polyclonal IB 1:10 000 1 hr RT W402B 
Promega, Madison,WI, USA 
HRP-conjugated 
rabbit anti-sheep 
IgG 
Rabbit polyclonal IB 1:5000 1 hr RT AP147P 
Millipore, MA, USA 
Rabbit IgG 
(whole 
molecule)-FITC 
Sheep polyclonal IF 1:250 30 min RT F7512 
Sigma-Aldrich, MO, USA 
Rabbit TrueBlot: 
Anti-Rabbit IgG 
HRP 
Goat polyclonal IP 1:2000 1 hr RT 18-8816 
eBioscience, CA, USA 
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min each) and then heat-induced epitope retrieval was performed using 0.01 M sodium 
citrate buffer (SC), pH 6.0. SC buffer was heated in a water bath at 95 °C, after which 
slides were immersed in the hot solution for 10 min and then transferred to a fresh 
solution at 95°C. Heat-induced epitope retrieval was repeated 4 times. Slides were air 
dried for 5 min then washed in PBS followed by a 15 minute incubation of sections in 1 
mg/mL trypsin (4mM CaCl2, 200mM Tris, pH 7.7; Sigma; Cat# T7168) at RT. Slides 
were rinsed with PBS. Tissue sections were blocked with 5 % normal goat serum/1 % 
horse serum in PBS for 1 h and incubated overnight with an HspB8 or Bag3 specific 
antibody, with agitation at 4 °C (Table 2.1). Both antibodies were diluted in blocking 
solution for all experiments and a non-specific IgG of the appropriate species, at the same 
effective concentration, served as a negative control (Table 2.1). Following incubation, 
sections were washed in PBS and incubated with fluorescein isothiocyanate (FITC)-
conjugated sheep anti-rabbit IgG while shaking at RT for 30 min (Table 2.2). Sections 
were washed 3 times with cold PBS, which contained 0.02 % Tween-20, and mounted 
with Vectashield containing 4', 6-diamidino-2-phenylindole (DAPI) for nuclear staining 
(Vector Laboratories; Cat# H-1200 Burlington, ON, Canada). A Leica DMIRE2 
microscope (Leica Microsystem (Canada) Inc., Richmond Hill, ON, Canada) equipped 
with epi-fluorescence optics and a QImaging Retiga EXi Camera (QImaging, Surrey, BC, 
Canada) was used to view sections and collect images. Images were collected and 
analyzed with Improvision Openlab 5 software (PerkinElmer, Waltham, MA, USA). 
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2.5 Immunoprecipitation (IP) Analysis 
 Human Telomerase Reverse Transcriptase- Human myometrial (hTERT-HM) cell 
lysates or rat myometrial tissue lysates from NP, d15 and d23 of gestation were diluted in 
RIPA buffer (containing Phosphatase Inhibitor Cocktail and Complete and Mini EDTA-
free protease inhibitors) to a final concentration of 1 µg/µl. The lysates were then pre-
cleared using 20 µl of Protein-A Sepharose 4B for 1 h at 4 °C.  Following centrifugation 
at 200 rcf for 1 min, the pellets were discarded and 3 µl of a HspB8 or Bag3 specific 
antibody (generous gifts from Dr. Jacques Landry Laboratory; [178, 183]) were added to 
each sample. The lysates were incubated on a nutator overnight at 4 °C. Twenty 
microlitres of Protein-A Sepharose 4B was added to each antibody-lysate mixture and 
incubated overnight at 4 °C. Following centrifugation at 500 rcf for 5 min, the 
supernatants were discarded and the pellets were washed 4 times with RIPA buffer 
(containing Phosphatase Inhibitor Cocktail and Complete and Mini EDTA-free protease 
inhibitors), with repeated centrifugations at 500 rcf. Finally each pellet was resuspended 
in 4X SDS PAGE buffer, heated at 95 °C for 5 min and centrifuged at 1200 rcf. Samples 
were analyzed by SDS-PAGE and immunoblot analysis. Blots were processed using the 
immunoblot technique previously described (Section 2.3) with one exception: following 
primary antibody incubation blots were probed with TrueBlotTM HRP-conjugated Anti-
rabbit IgG for 1 h with shaking at RT (Table 2.2). 
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2.6 Cell Culture 
2.6.1 Human Myometrial Cell Line hTERT-HM 
 An immortalized human myometrial cell line, hTERT-HM, was a very generous 
gift from Dr. Ann Word (Southwestern Medical Center, Dallas, TX, USA) and was used 
for cell experiments. This line was derived from myometrial tissue of women undergoing 
hysterectomy. Retroviral infection was used to express the catalytic subunit of telomerase 
in these myometrial cells. The hTERT-HM cells retain morphological characteristics of 
proliferating smooth muscle cells in culture including: elongated cell shape with a central 
nucleus, a sheetlike growth pattern at confluence and expression of smooth muscle-
specific actin [229]. This cell line expresses markers of uterine smooth muscle such as, 
the OTR, PR, calponin, caldesmon and smooth muscle α-actin and it maintains 
responsiveness to 17β-estradiol. The expression of these markers indicates that the 
hTERT-HM cell line retains the phenotypic characteristics of human myometrial smooth 
muscle cells and may serve as a useful model to study human myometrial function [229]. 
 Cells were cultured in 75 cm2 flasks at 37 °C under a 5 % CO2 in air environment 
with Dulbecco’s modified Eagle’s medium (DMEM) nutrient mixture F-12 (Ham) 1X 
(DMEM/F12 1:1; (Invitrogen, Burlington, ON, Canada) which was supplemented with 
10 % fetal bovine serum (FBS; PAA Laboratories, Etobicoke, ON, Canada) and 1 % 
pen/strep (100 U/ml penicillin, 100 µg/ml streptomycin; Invitrogen, Burlington, ON, 
Canada). Cells were cultured until they were 70-80 % confluent then used for various 
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experiments.  
2.6.2 Collection of Cell Protein Lysates 
 Cells were washed in 5 mL of PBS and subsequently placed on ice. Nonidet-P40 
(NP-40) lysis buffer (containing Phosphatase Inhibitor Cocktail and CompleteTM Mini 
EDTA-free protease inhibitors; Roche Molecular Biochemicals, Laval, Quebec, Canada; 
Cat# 04906837001, 12454800) were added to each dish and left on ice for ~2 min. Cells 
were removed from the dish using a cell scraper and placed into a 1.5 mL microfuge tube. 
Samples were then homogenized in NP-40 buffer using a bead mill and centrifuged at 
11000 rcf for 15 min at 4 oC. Supernatants were collected and the protein concentrations 
of these samples were obtained using the Bradford Assay [230]. Samples were then 
stored at -80 oC.	  
2.6.3 Angiotensin II-induced Hypertrophy Experiment  
Angiotensin II has been found to induce hypertrophy of human airway smooth 
muscle cells, vascular smooth muscle cells and cultured rat aortic smooth muscle cells 
[231-233]. For Angiotensin II (Ang II) experiments ~2.0 x 104 hTERT-HM cells were 
each seeded in four 25 cm2 flasks. For the first night, cells were cultured in a 5 % CO2 in 
air incubator at 37 °C in normal media supplemented with 10 % FBS and 1 % pen/strep. 
After 24 h, all cells were cultured in serum free media supplemented with 1 % pen/strep. 
After an additional 24 h, two flasks were cultured in serum free media supplemented with 
1000 nM Ang II (05-23-0101, Calbiochem, San Diego, CA, USA) and 1 % pen/strep, 
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while the two vehicle control flasks were cultured in serum free media supplemented 
with an equivalent volume of ultrapure distilled water (DNAse, RNAse free; Invitrogen, 
Burlington, ON, Canada) and 1 % pen/strep. After an additional 24 h of culture in Ang II 
supplemented medium, protein lysates were collected (Section 2.6.2). 
2.6.4 Plasmids 
 A mammalian expression vector encoding a myc-tagged human HspB8 cDNA 
construct (pCImycHspB8) and a mammalian expression vector encoding a myc-tagged 
human Bag3 cDNA construct (pCImycBag3) were very generous gifts from the 
laboratory of Dr. Jacques Landry [178, 211].  
 To cultivate the acquired plasmids, 50 µL of DH5α competent cells were thawed 
on ice and transferred to a 15 mL Falcon tube. Plasmid (25 ng) was added to the DH5α 
cells and the mixture was incubated on ice for 30 min. The mixture was heated at 42 °C 
for 90 s and subsequently incubated on ice for 2 min. One mL of pre-warmed cell culture 
media (without antibiotic) was added to the mixture and the culture agitated at 220 rpm 
for 1 h at 37 °C. The culture was spread on pre-warmed agar plates containing ampicillin 
(100 µg/mL) and plates were inverted and incubated overnight at 37 °C. Single colonies 
were selected for inoculation of 3 mL mini-cultures containing ampicillin and were left 
shaking overnight at 220 rpm at 37 °C. Plasmid DNA was purified using a PureLink 
Quick Plasmid Miniprep Kit (Invitrogen, Burlington, ON, Canada) according to the 
manufacturer’s instructions and then the DNA concentrations of all samples were 
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determined using a NanoDrop Spectrophotometer. After determining the DNA 
concentration, samples were prepared for restriction endonuclease digestion. Each 
digestion contained 1 µg DNA, 1 µL 10X buffer (depending on restriction enzymes), 10 
µg/µL restriction enzyme and had a total volume of 10 µL, made up with water. 
Restriction endonuclease digestions of DNA were conducted at 37 °C for 1 h, except for 
the uncut plasmids. Before loading samples on to an agarose gel, 1 µL of 6X loading dye 
was added to each sample. Digestions were analyzed on a 1% agarose gel prestained with 
SYBR safe by electrophoresis at 100 V for approximately 40 min. Next, a GeneElute HP 
Plasmid Midiprep Kit (Sigma-Aldrich, MO, USA) was used to purify the plasmid DNA 
in larger scale according to the manufacturer’s instructions and restriction endonuclease 
digestion of all samples was conducted as described above. 
 The cDNA of myc-tagged human HspB8 was inserted at the EcoRI/XbaI 
restriction sites of pCI (Promega) (Figure 2.1). Therefore, following purification of the 
plasmid DNA the plasmid was verified by restriction endonuclease digestion using 
restriction enzymes EcoRI, NotI, and BamHI (Invitrogen, Burlington, ON, Canada). 
EcoRI and NotI were used to verify that the plasmid was present, as NotI is also found in 
the multiple cloning site. Finally, to verify that the plasmid was the correct size and to 
verify the orientation of the insert, BamHI was used as the restriction enzyme. BamHI 
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Figure 2.1 pCI mammalian expression vector encoding cDNA of human myc-tagged 
HspB8 or Bag3. The cDNA was inserted at the EcoRI/XbaI restriction sites of pCI 
(Promega).   
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cuts both the insert and the vector once and the expected band for the cDNA insert was 
465 base pairs (bp).    
 The cDNA of myc-tagged human Bag3 was inserted at the EcoRI/XbaI restriction 
sites of pCI (Promega) (Figure 2.1). Therefore, following purification of the plasmid it 
was verified by restriction endonuclease digestion using the restriction enzymes EcoRI 
and XbaI (Invitrogen, Burlington, ON, Canada). As the cDNA was inserted at the 
EcoRI/Xba1 restriction sites of pCI initially, the restriction enzymes XbaI and EcoRI 
were appropriate for verification.  
2.6.5 Optimization of Cell Transfection 
 pEGFP-C3 expression vectors were transiently transfected into hTERT-HM cells 
using an Amaxa basic nucleofector kit for primary smooth muscle cells (Lonza, 
Mississauga, ON, Canada; Cat# VPI-1004). First, cells were cultured until approximately 
70-80 % confluent, then washed in 5 mL of PBS followed by addition of 1 mL of trypsin 
to each 75 cm2 dish for 5 min at 37°C. One mL of media was then added to each dish to 
inactivate the trypsin and cells from all dishes were pooled into a single 15 mL centrifuge 
tube. Cells were counted and approximately 1 x 106 cells were added to different 15 mL 
tubes. Each tube was centrifuged at 700 rpm for 10 min and the excess media was 
removed. The pellet was resuspended with 100 µL Nucleofector solution (82 µL 
Nucleofector solution + 18 µL Supplement) and 4 µL of pEGFP-C3 expression vector 
was added. The solution was then transferred to a cuvette and a Lonza nucleofector was 
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used to transfect the cells using the appropriate program (A-033, D-033, P-013, P-042, U-
025, B-017) or no program to serve as a control. Following transfection, 0.5 mL of pre-
warmed media was added to the cuvette and the entire solution then subsequently 
transferred to 6 mL of pre-warmed culture media in a 25 cm2 tissue culture flask. Each 
flask was incubated for 10 min at 37 oC in a tissue culture incubator. Finally, the contents 
of each 25 cm2 flask were equally distributed among each well of a 6 well plate (~2 mL 
per well) and placed in a tissue culture incubator, containing 5 % CO2 in air, at 37 oC for 
72 h. Cells were photographed at 24 h and 48 h under brightfield and epi-fluorescence 
illumination for assessment of transfection efficiency and cell numbers. 
2.6.6 Transfection of cells 
 pCImycHspB8, pCImycBag3 and pEGFP-C3 expression vectors were transiently 
co-transfected into hTERT-HM cells, using an Amaxa basic nucleofector kit for primary 
smooth muscle cells, in order to assess their sufficiency to induce cellular hypertrophy. 
Following transfection optimization, program A-033 was utilized for all transfection 
experiments. Three 75 cm2 tissue culture dishes of hTERT-HM cells were used for each 
transfection experiment, using the methods described above (section 2.6.5). For co-
transfection experiments of a single expression vector and transfection indicator plasmid, 
a total of 2 µg of plasmid DNA was added to each cell sample. For co-transfection 
experiments with two transfection vectors (pCImycHspB8 and pCImycBag3) and 
transfection indicator plasmid, a total of 2.5 µg of plasmid DNA were added to each cell 
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sample. After transfection, cells were cultivated for 72 h followed by collection of protein 
lysates.  
2.7 Flow Cytometry 
 Cells to be analyzed by flow cytometry (see Sections 2.6.3 and 2.6.6) were 
labeled with far-red fluorescent reactive dye (Cy5) using a LIVE/DEAD® Fixable Dead 
Cell Stain Kit (L10120, Invitrogen, Burlington, ON, Canada) according to the 
manufacturers’ instructions. This assay is based on the reaction of a fluorescent reactive 
dye with cellular amines. The reactive dye can permeate the compromised membranes of 
necrotic cells and react with free amines in the interior and on the cell surface, resulting 
in intense fluorescent staining. However, the reactive dye can only react with the cell-
surface amines of viable cells, resulting in dim fluorescent staining. The difference in 
intensity between live and dead cell populations is usually greater than 50-fold. Briefly, 
cells were trypsinized and then a sample of cells in suspension containing at least 1 x 106 
cells was centrifuged, washed and resuspended in PBS. One microlitre of reconstituted 
fluorescent reactive dye (far red fluorescent reactive dye) was then added to 1 mL of the 
cell suspension and incubated on ice for 30 min, protected from light. Subsequently, cells 
were washed in PBS and resuspended in 900 µl of PBS and 100 µl of 37 % 
formaldehyde. Cells were incubated at RT for 15 min and then washed in PBS with 1 % 
BSA. Finally, cells were resuspended in 1 mL of PBS with 1 % BSA and then analyzed 
by flow cytometry using a BD FACSCalibur™ flow cytometer (far red fluorescent 
reactive dye: 633/635 nm excitation and ~665 nm emission). 
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2.8 Protein/DNA ratio 
 Protein/DNA ratios were determined using a SurePrepTM RNA/DNA/Protein 
Purification Kit (Fisher BioReagents, Fairlawn, NJ USA) according to the manufacturer’s 
instructions. This kit allowed for isolation of both proteins and purification of genomic 
DNA. Briefly, 0.8 x 106 hTERT-HM cells were used for cell lysate preparation. Initially, 
total RNA was purified using RNA wash solution/RNA elution buffer and the 
flowthrough, containing total protein, was retained. Subsequently, genomic DNA from 
the flowthrough was purified using genomic DNA wash solution and genomic DNA 
elution buffer. DNA (A260) and protein (A280) concentrations were determined with a 
Nanodrop Spectrophotometer. 
2.9 Data Analysis 
 Densitometric analysis was performed on immunoblots using ImageJ software 
(National Institutes of Health, USA). Densitometric measurements of the protein of 
interest were normalized to the loading control calponin or GAPDH and presented as the 
mean ± standard error of the mean (SEM). GraphPad Instat version 3.0 (GraphPad 
Software, San Diego, CA, USA, www.graphpad.com) was used to perform statistical 
analysis and graphs were prepared using GraphPad Prism version 5.0 (GraphPad 
Software). Data from normal gestational profiles and progesterone experiments were 
subjected to a one-way analysis of variance (ANOVA) or a two-way ANOVA, 
respectively. Data that was found to have significance from a one- way or two-way 
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ANOVA was then subjected to Newman-Keuls post-hoc test to determine pair wise 
significance. Data from unilateral pregnancy and RU486 experiments were subjected to a 
student t-test. The differences were considered significant if the p-value was less than 
0.05.  
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Chapter Three 
Results 
3.1 Expression of HspB8 During Normal Pregnancy and Labour 
3.1.1 Immunoblot Analysis of HspB8 Protein 
 Immunoblot analysis was performed to characterize HspB8 protein expression in 
non-pregnant and pregnant rat myometrium throughout the gestational period. HspB8 and 
calponin protein were detected at their predicted molecular weights, 22 kDa and 34 kDa 
respectively (Figure 3.1.1A). Following densitometric analysis of immunoblots, a one-
way ANOVA revealed that HspB8 protein expression changed significantly over 
gestation (p< 0.05; n=4/day). HspB8 protein expression was particularly elevated at d15, 
d17 and d19 compared to expression at NP and d6. These results were confirmed by 
additional immunoblot analysis using a second HspB8 specific antibody from Cell 
Signaling (2.1; Figure 3.1.1C). The two antibodies utilized were polyclonal antisera; 
however, the antibody from LifeSpan BioSciences was designed to recognize the N- 
terminus of HspB8 whereas the antibody from Cell Signaling detected endogenous levels 
of total HspB8 protein. 
3.1.2 Immunofluorescence Detection of HspB8 Protein 
 
 To determine the spatial localization of HspB8 protein in the myometrium 
throughout gestation, immunofluorescence detection was completed. Detection of HspB8 
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Figure 3.1.1 Immunoblot analysis of HspB8 protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of HspB8 protein and calponin are shown. 
Analysis was performed using a HspB8 specific antibody (LifeSpan BioSciences). (B) 
The relative protein expression of HspB8 was analyzed using densitometric analysis. The 
data were presented as the mean ± SEM of the relative optical density of HspB8 
normalized to the optical density of calponin. Values are from four independent 
experiments. One-way ANOVA revealed that HspB8 protein expression changed 
significantly overall. HspB8 protein expression was significantly elevated at d15, d17 and 
d19 compared to expression at NP and d6 (*, p< 0.05; Newman-Keuls, post-hoc test; 
n=4/day). Days 6, 12, 15, 17, 19, 21, 22, and 23 represent gestational time points. NP, 
non-pregnant; PP, 1 day postpartum. (C) Representative immunoblots of HspB8 protein 
and calponin are shown. Analysis was performed using a HspB8 specific antibody (Cell 
Signaling). Results further confirm those received using the other commercially available 
antibody purchased from LifeSpan Biosciences. 
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protein in the circular and longitudinal muscle layers revealed that it was primarily 
localized in the cytoplasm of cells throughout gestation (Figure 3.1.2- 3.1.5). At higher 
magnification, it was confirmed that HspB8 protein was localized in the cytoplasm and 
there was an absence of any nuclear staining (Figure 3.1.6). It was also noted that there 
was particularly intense cytoplasmic staining on d15 and d17 of gestation, indicating 
concentrated subcellular localization of HspB8 protein.  
3.2 Immunofluorescence Detection of HspB8 Protein in Rat Heart Tissue 
Although immunoblot analysis demonstrated significant changes in HspB8 
protein expression throughout gestation, there was only a slight apparent increase in 
immunofluorescence detection of HspB8 protein. Thus, as a means to assess the quality 
of the HspB8 specific antibody for immunofluorescence procedures, immunolocalization 
of HspB8 protein was examined in rat heart tissue. Depre et al. (2006) reported HspB8 
protein expression in heart muscle particularly in the cytoplasm of myocytes [234]. 
Detection of HspB8 protein was localized to the cytoplasm of rat myocytes (Figure 3.2.1) 
as previously reported, confirming the specificity of the antisera used. 
 
3.3 Analysis of Proteins Associated with HspB8 during Pregnancy 
3.3.1 Expression of Bag3 protein 
 Immunoblot analysis was performed to characterize Bag3 protein expression in 
non-pregnant and pregnant rat myometrium throughout the gestation period. 
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Figure 3.1.2 Immunofluorescence detection of HspB8 protein in the circular muscle 
layer of NP rat myometrium and myometrium from d6 to d17 of gestation. The images 
demonstrate mainly cytoplasmic localization of the protein and an absence of nuclear 
staining (n=3/day) using a HspB8-specific antibody (Lifespan BioSciences). Ctrl = 
control, rabbit IgG. Scale bar = 50 µm. 
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Figure 3.1.3 Immunofluorescence detection of HspB8 protein in the circular muscle 
layer of rat myometrium at d19 to d23 of gestation and PP. The images demonstrate 
mainly cytoplasmic localization of the protein and an absence of nuclear staining 
(n=3/day) using a HspB8 specific antibody (LifeSpan BioSciences). Ctrl = control, rabbit 
IgG. Scale bar = 50 µm. 
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Figure 3.1.4 Immunofluorescence detection of HspB8 protein in the longitudinal muscle 
layer of NP rat myometrium and d6 to d17 of gestation. Detection of HspB8 protein, 
using a HspB8 specific antibody (LifeSpan Biosciences), in the longitudinal muscle layer 
demonstrated that it was primarily and readily localized in the cytoplasm of myometrial 
cells and there was an absence of nuclear staining (n=3/day). Arrows indicate blood 
vessels. Ctrl = control, rabbit IgG. Scale bar = 50 µm. 
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Figure 3.1.5 Immunofluorescence detection of HspB8 protein in the longitudinal muscle 
layer of rat myometrium at d19 to d23 of gestation and PP. Detection of HspB8 protein, 
using a HspB8 specific antibody (LifeSpan BioSciences), in the longitudinal muscle layer 
demonstrated that it was primarily localized in the cytoplasm of myometrial cells and 
there was an absence of nuclear staining (n=3/day). Ctrl = control, rabbit IgG. Scale bar = 
50 µm. 
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Figure 3.1.6 Immunofluorescence detection of HspB8 protein in the cytoplasm of 
longitudinal muscle cells of rat myometrium. Sections were probed with a HspB8 
specific antibody (LifeSpan BioSciences). The image (d15+ Dapi) demonstrates that 
there was no nuclear staining (arrows indicate the nucleus); thus, indicating cytoplasmic 
localization of the protein within myometrial cells (n=3/day). Ctrl = control, rabbit IgG. 
Scale bar = 50 µm. 
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Figure 3.2.1 Immunofluorescence detection of HspB8 protein in rat heart tissue sections. 
Analysis was conducted using a HspB8 specific antibody (LifeSpan BioSciences). The 
images demonstrate cytoplasmic localization of the protein within heart myocytes, 
detection near cell membranes and the absence of any nuclear staining. Based on 
previous studies, the expected staining for the heart was clear localization in the 
cytoplasm. Arrows on the control indicate red blood cells. Ctrl = control, rabbit IgG. 
Scale bar = 50 µm. 
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Immunoblot analysis was carried out with a Bag3 specific antibody at the time points 
previously described (Table 2.1; Section 2.2.1). Bag3 and calponin protein were detected 
at their predicted molecular weights, 74 kDa and 34 kDa respectively (Figure 3.3.1). 
Following densitometric analysis, one-way ANOVA revealed that Bag3 protein 
expression changed significantly over gestation (p< 0.05; n=4/day). Bag3 protein 
expression was significantly elevated at d15, compared to expression at NP, and at d17 
compared to NP, d6, d23 and PP. Following immunoblot analysis it was noted that 
additional protein bands were detected at different molecular weights, possibly 
representing cleavage products of Bag3 (Figure 3.3.2). 
3.3.2 Immunofluorescence Detection of Bag3 Protein 
To determine the spatial localization of Bag3 protein throughout gestation, 
immunofluorescence detection was completed. Detection of Bag3 protein in the circular 
and longitudinal muscle layers of rat myometrium indicated that it was homogeneously 
distributed in the cytoplasm of myometrial cells. Specifically, there was perinuclear 
localization of Bag3 protein in addition to general cytoplasmic localization, and an 
absence of nuclear staining (Figure 3.3.3-3.3.6). Immunostaining was more homogeneous 
and slightly more intense around d15 and d17 in comparison to early time points.  
3.3.3 Expression of Bag1 Protein 
 One important function of Bag1 is to mediate protein quality control by targeting 
selected proteins for proteasome-mediated degradation, likely also an essential process  
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Figure 3.3.1 Immunoblot analysis of Bag3 protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of Bag3 protein and calponin are shown. 
(B) The relative expression of Bag3 was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of Bag3 normalized to 
the optical density of calponin. Values are from four independent experiments. One-way 
ANOVA revealed that Bag3 protein expression changed significantly overall. Bag3 
protein expression was significantly elevated at d15 compared to expression at NP (*, p< 
0.05; Newman-Keuls, post-hoc test; n=4/day). Bag3 protein expression was also 
significantly elevated at d17 compared to NP, d6, d23 and PP (**, p< 0.05). Days 6, 12, 
15, 17, 19, 21, 22, and 23 represent gestational time points. NP, non-pregnant; PP, 1 day 
postpartum.  
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Figure 3.3.2 Expression of potential Bag3 cleavage products in rat myometrium during 
gestation. Representative immunoblot probed with a Bag3 specific antibody. Full-length 
Bag3 protein has a molecular weight of approximately 74 kDa however, additional bands 
were also detected at approximately 40 kDa and 25 kDa between NP and ~ d19 of 
gestation. These bands may represent possible cleavage products of Bag3 protein. Arrows 
indicate the unknown bands recognized by the Bag3 specific antibody. 
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Figure 3.3.3 Immunofluorescence detection of Bag3 protein in the circular muscle layer 
of NP rat myometrium and d6 to d17 of gestation. The images demonstrate mainly 
cytoplasmic localization of the protein, as well as an absence of nuclear staining 
(n=3/day). Arrows indicate perinuclear localization. Ctrl = control, rabbit IgG. Scale bar 
= 50 µm. 
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Figure 3.3.4 Immunofluorescence detection of Bag3 protein in the circular muscle layer 
of rat myometrium at d19 to d23 of gestation and PP. The images demonstrate mainly 
cytoplasmic localization of the protein, as well as an absence of nuclear staining 
(n=3/day). Arrows indicate perinuclear localization. Ctrl = control, rabbit IgG. Scale bar 
= 50 µm. 
	    
D19
100
Ctrl
D22 D23
PP
D21
101 
 
	  
	  
	  
	  
	  
	  
Figure 3.3.5 Immunofluorescence detection of Bag3 protein in the longitudinal muscle 
layer of NP rat myometrium and myometrium from d6 to d17 of gestation. Detection of 
Bag3 protein in the longitudinal muscle layer demonstrated that it was primarily and 
readily localized in the cytoplasm of myometrial cells. There was also an absence of 
nuclear staining (n=3/day). Ctrl = control, rabbit IgG. Scale bar = 50 µm. 
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Figure 3.3.6 Immunofluorescence detection of Bag3 protein in the longitudinal muscle 
layer of rat myometrium at d19 to d23 of gestation and PP. Detection of Bag3 protein in 
the longitudinal muscle layer demonstrated that it was primarily localized in the 
cytoplasm of myometrial cells. There was also an absence of nuclear staining (n=3/day). 
Ctrl = control, rabbit IgG. Scale bar = 50 µm. 
  
104
D19 D21
D22 D23
PP Ctrl
105 
 
for the maintenance of pregnancy [199]. Immunoblot analysis was performed to 
characterize Bag1 protein expression in non-pregnant and pregnant rat myometrium 
throughout the gestational period. Immunoblot analysis was carried out with a Bag1 
specific antibody at the time points previously mentioned (Table 2.1; Section 2.2.1). 
Bag1 and calponin protein were detected at their predicted molecular weights, 38 kDa 
and 34 kDa respectively (Figure 3.3.7). Following immunoblot analysis it was noted that 
a doublet protein was visible on immunoblots, representing a possible phosphorylated 
form of Bag1. Previously published results also suggested the presence of a doublet band 
of ~38 kDa in peripheral blood mononuclear cells and tonsil as evidence of a 
phosphorylated form of Bag1 [235]. One-way ANOVA of both bands revealed that Bag1 
protein expression changed significantly over gestation (p< 0.05; n=4/day). Bag1 protein 
expression was significantly expressed at NP, d6 and d12 compared to d21, d22 and at 
d12 compared to d15, d19, d21, d22, d23, PP.  
 
3.3.4 Expression of Hsp70 and Hsc70 Protein 
 
 It is well known that the Bag proteins are a family of co-chaperones that are 
capable of interacting with the ATPase domain of Hsc70/Hsp70 through their structural 
Bag domain [188, 189]. Therefore, to determine the levels of Hsp70 protein throughout 
normal pregnancy and labour in the rat myometrium, immunoblot analysis was 
performed. Immunoblot analysis was carried out with an Hsp70 specific antibody 
throughout gestation (Table 2.1). Hsp70 and calponin protein bands were detected at their 
predicted molecular weights, 70 kDa and 34 kDa respectively (Figure 3.3.8). Following 
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Figure 3.3.7 Immunoblot analysis of Bag1 protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of Bag1 protein and calponin are shown. 
(B) The relative expression of Bag1 was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of Bag1 normalized to 
the optical density of calponin. Values are from four independent experiments. One-way 
ANOVA revealed that Bag1 protein expression changed significantly overall. Bag1 
protein expression was significantly elevated at NP, d6 and d17 compared to d21 and d22 
(*, p< 0.05; Newman-Keuls, post-hoc test; n=4/day).. Bag1 protein expression was also 
significantly elevated at d12 compared to d15, d19, d21, d22, d23 and PP (**, p< 0.05). 
Days 6, 12, 15, 17, 19, 21, 22, and 23 represent gestational time points. NP, non-
pregnant; PP, 1 day postpartum. 
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Figure 3.3.8 Immunoblot analysis of Hsp70 protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of Hsp70 protein and calponin are shown. 
(B) The relative expression of Hsp70 was analyzed using densitometric analysis. The 
data were presented as the mean ± SEM of the relative optical density of Hsp70 
normalized to the optical density of calponin. Values are from four independent 
experiments (n=4/day). One-way ANOVA revealed that Hsp70 protein expression 
changed significantly overall. Hsp70 protein expression was significantly elevated at 19, 
21, 22, 23 and PP ccompared to expression at NP and d6 (*, p< 0.05; Newman-Keuls, 
post-hoc test; n=4/day). Furthermore, Hsp70 protein expression on d23 and PP was 
significantly higher than d12 and d15 (**, p< 0.05). Days 6, 12, 15, 17, 19, 21, 22, and 23 
represent gestational time points. NP, non-pregnant; PP, 1 day postpartum. 
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immunoblot and densitometric analysis, one-way ANOVA revealed that Hsp70 protein 
expression changed significantly over gestation (p< 0.05; n=4/day). Protein expression 
was significantly elevated at d19, d21, d22 and d23 compared to expression at NP and d6. 
Furthermore, Hsp70 protein expression was significantly higher on d23 and PP compared 
to d12 and d15.  
Immunoblot analysis was also performed to characterize Hsc70 protein 
expression in non-pregnant and pregnant rat myometrium throughout the gestational 
period. Immunoblot analysis was carried out with an Hsc70 specific antibody throughout 
gestation (Table 2.1). Hsc70 and calponin protein bands were detected at their predicted 
molecular weights, 73 kDa and 34 kDa respectively (Figure 3.3.9). Following 
immunoblot and densitometric analysis one-way ANOVA revealed that Hsc70 protein 
expression did not change significantly throughout gestation (p> 0.05; n=4/day). Hsc70 
protein was constitutively expressed throughout pregnancy.  
 
3.3.5 Expression of CHIP Protein 
 
HspB8 has been found to be part of a multi-heteromeric complex, comprised of 
HspB8, Bag3, Hsc70 and CHIP, which is responsible for the removal of misfolded 
proteins through macroautophagy activation. Therefore, immunoblot analysis was 
performed to characterize CHIP protein expression in non-pregnant and pregnant rat 
myometrium throughout the gestational period. Immunoblot analysis was carried out with 
a CHIP specific antibody throughout gestation (Table 2.1). CHIP and calponin protein  
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Figure 3.3.9 Immunoblot analysis of Hsc70 protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of Hsc70 protein and calponin are shown. 
(B) The relative expression of Hsc70 was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of Hsc70 normalized to 
the optical density of calponin. Values are from four independent experiments. One-way 
ANOVA revealed that Hsc70 expression did not change significantly overall (p >0.05; 
n=4/day). Hsc70 protein is constitutively expressed throughout gestation. Days 6, 12, 15, 
17, 19, 21, 22, and 23 represent gestational time points. NP, non-pregnant; PP, 1 day 
postpartum. 
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bands were detected at their predicted molecular weights, 39 kDa and 34 kDa 
respectively (Figure 3.3.10). Following immunoblot and densitometric analysis, one-way 
ANOVA revealed that CHIP protein expression did not change significantly throughout 
gestation (p> 0.05; n=4/day); CHIP protein was constitutively expressed throughout 
pregnancy.  
3.3.6 Expression of LC3II Protein 
 Thus far, the only known protein found on autophagosomes is LC3II and as a 
result, it is widely used as a marker for autophagosomes and the process of 
macroautophagy [218]. As a means to assess autophagosome accumulation, immunoblot 
analysis was performed to characterize LC3II protein expression in non-pregnant and 
pregnant rat myometrium throughout gestation. Immunoblot analysis was carried out 
with a LC3II specific antibody throughout gestation (Table 2.1). LC3II and calponin 
protein bands were detected at their predicted molecular weights, 16 kDa and 34 kDa 
respectively (Figure 3.3.11). Following immunoblot and densitometric analysis, one-way 
ANOVA revealed that LC3II protein expression changed significantly over gestation. 
LC3II protein expression was significantly elevated at PP compared to expression at NP, 
d6 and d12 (p<0.05; n=4/day). 
3.3.7 Expression of Pser51-eIF2α Protein 
 Carra et al. (2009) suggest that HspB8 and Bag3 induce phosphorylation of the α-
subunit of the translation initiator factor eIF2 in HEK-293 cells which ultimately results 
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Figure 3.3.10 Immunoblot analysis of CHIP protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of CHIP protein and calponin are shown. 
(B) The relative expression of CHIP was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of CHIP normalized to 
the optical density of calponin. Values are from four independent experiments. One-way 
ANOVA revealed that CHIP expression did not change significantly throughout gestation 
(p> 0.05; n=4/day). CHIP protein is constitutively expressed throughout gestation. Days 
6, 12, 15, 17, 19, 21, 22, and 23 represent gestational time points. NP, non-pregnant; PP, 
1 day postpartum. 
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Figure 3.3.11 Immunoblot analysis of LC3II protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of LC3II protein and calponin are shown. 
(B) The relative expression of LC3II was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of LC3II normalized to 
the optical density of calponin. Values are from four independent experiments. One-way 
ANOVA revealed that LC3II protein expression changed significantly overall. LC3II 
protein expression was significantly elevated at PP compared to expression at NP, d6 and 
d12 (*, p< 0.05; Newman-Keuls, post-hoc test; n=4/day). Days 6, 12, 15, 17, 19, 21, 22, 
and 23 represent gestational time points. NP, non-pregnant; PP, 1 day postpartum. 
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in translational shut-down and activation of the macroautophagy process [186]. To begin 
assessing whether HspB8 and Bag3 could be inducing phosphorylation of the α-subunit 
of eIF2 in a temporal-specific manner within the myometrium, immunoblot analysis was 
performed to characterize Pser51-eIF2α protein expression in non-pregnant and pregnant 
rat myometrium throughout gestation. Immunoblot analysis was carried out with a 
Pser51-eIF2α specific antibody throughout gestation (Table 2.1). Pser51-eIF2α and 
calponin proteins were detected at their predicted molecular weights, 36 kDa and 34 kDa 
respectively (Figure 3.3.12). Following immunoblot and densitometric analysis, one-way 
ANOVA revealed that Pser51-eIF2α protein expression did not change significantly 
throughout gestation (p> 0.05; n=4/day). Pser51-eIF2α protein was constitutively 
expressed throughout pregnancy and post-partum. 
 
3.4 The Effect of Uterine Distension on HspB8 Expression: Unilateral Pregnancy 
Model 
3.4.1 Expression of HspB8 Protein 
As immunoblot analysis demonstrated an increase in HspB8 protein expression at 
d15, d17 and d19 of gestation, a period of stretch-induced hypertrophy, the role of uterine 
distension on regulating HspB8 protein expression was assessed using a unilateral 
pregnancy model [14]. Immunoblot analysis was performed using protein lysates from 
the stretched (gravid) and non-stretched (non-gravid) uterine horns at d15, d19 and d23 
and an HspB8 specific antibody (Table 2.1). There were no statistically significant 
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Figure 3.3.12 Immunoblot analysis of Pser51-eIF2α protein expression in pregnant rat 
myometrium. (A) Representative immunoblots of Pser51-eIF2α protein and calponin are 
shown. (B) The relative expression of Pser51-eIF2α was analyzed using densitometric 
analysis. The data were presented as the mean ± SEM of the relative optical density of 
Pser51-eIF2α normalized to the optical density of calponin. Values are from four 
independent experiments. One-way ANOVA revealed that Pser51-eIF2α expression did 
not change significantly overall (p> 0.05; n=4/day). Pser51-eIF2α protein is 
constitutively expressed throughout gestation. Days 6, 12, 15, 17, 19, 21, 22, and 23 
represent gestational time points. NP, non-pregnant; PP, 1 day postpartum. 
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changes in the level of detection of HspB8 protein between the non-gravid and gravid 
samples at any of the time points examined (Figure 3.4.1).   
3.4.2 Immunofluorescence Detection of HspB8 Protein 
To determine if the spatial localization of HspB8 protein changed due to uterine 
stretch, immunofluorescence detection was performed. Detection of HspB8 protein in the 
circular and longitudinal muscle layers at d19 and d23 of gestation demonstrated that 
HspB8 protein was primarily localized to the cytoplasm of myometrial cells and that 
there was an absence of nuclear staining in both the non-gravid and gravid uterine 
samples (Figure 3.4.2- 3.4.3). In addition, there were no marked differences in the level 
of detection of HspB8 protein between the non-gravid and gravid samples at the two time 
points analyzed.  
 
3.5 The Effect of Progesterone on HspB8 Expression 
 
3.5.1 Progesterone-induced Delayed Labour: Expression of HspB8 Protein 
 As HspB8 protein expression was elevated during this d15-d19 window of 
gestation compared to earlier time points (Figure 3.1.1), it was hypothesized that the 
observed pattern of HspB8 expression was under the influence of progesterone. Thus, 
administration of exogenous progesterone may further induce HspB8 protein expression.  
  
122 
 
 
 
 
 
 
Figure 3.4.1 HspB8 protein expression is not influenced by uterine stretch. 
Representative immunoblots of HspB8 protein and calponin detection are shown for three 
gestational time points, d15 (A), d19 (B) and d23 (C). Analysis was performed using a 
HspB8 specific antibody (Cell Signaling). Densitometric analysis revealed that there 
were no statistically significant differences in HspB8 protein expression between the non-
gravid and gravid samples at the time points examined (paired t-test; p> 0.05). Values are 
from 4 independent experiments (n=4/day) ± SEM. 
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Figure 3.4.2 Immunofluorescence detection of HspB8 protein in the circular muscle 
layer of rat myometrium in gravid (G) and non-gravid (NG) uterine horns. Sections were 
probed with a HspB8 specific antibody (LifeSpan BioSciences). Two representative time 
points of pregnancy are shown, d19 and d23. The images demonstrate cytoplasmic 
localization of the protein in myometrial cells; however, there was no visible marked 
change in the level of detection of HspB8 protein between the non-gravid and gravid 
samples at either time point (n=2/day). Ctrl = control, rabbit IgG. Scale bar = 50 µm. 
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Figure 3.4.3 Immunofluorescence detection of HspB8 protein in the longitudinal muscle 
layer of rat myometrium in gravid (G) and non-gravid (NG) uterine horns. Sections were 
probed with a HspB8 specific antibody (LifeSpan BioSciences). Two representative time 
points of pregnancy are shown, d19 and d23. The images demonstrate cytoplasmic 
localization of the protein in myometrial cells; however, there was no visible marked 
change in the level of detection of HspB8 between the non-gravid and gravid samples at 
either time point (n=2/day). Ctrl = control, rabbit IgG. Scale bar = 50 µm. 
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Animals were administered progesterone beginning on d20 of gestation and did not go 
into labour on d23 of gestation. Immunoblot analysis of HspB8 protein expression in 
myometrial tissue collected from vehicle and progesterone-treated rats indicated that 
progesterone administration significantly affected HspB8 protein expression (p<0.05; 
n=4/day; Table 2.1; Figure 3.5.1A). HspB8 and calponin protein bands were detected at 
their predicted molecular weights, 22 kDa and 34 kDa respectively. Densitometric 
analysis of immunoblot data and two-way ANOVA indicated that HspB8 protein 
expression at d23 in rats administered progesterone was significantly lower compared to 
expression in rats at d23 administered vehicle. Immunoblot analysis of the two treatment 
groups was also performed using another commercially available antibody (Cell 
Signaling) to further confirm the results (p<0.05; n=4/day; Table 2.1; Figure 3.5.1C). 
Overall, immunoblot analysis indicated that progesterone might have an inhibitory effect 
on HspB8 protein expression.  
 
3.5.2 RU486-induced Progesterone Withdrawal: Expression of HspB8 Protein 
 
 Upon administration of the progesterone receptor antagonist RU486 to pregnant 
rats on d18 of gestation, preterm labour is induced within 24 h. Immunoblot analysis of 
HspB8 protein expression in myometrial tissue collected from vehicle and RU486-treated 
rats indicated that a functional progesterone withdrawal significantly affected HspB8 
protein expression (p<0.05; n=4/day; Figure 3.5.2). HspB8 protein expression was 
significantly increased following administration of RU486. This result further suggests 
that progesterone may negatively regulate HspB8 gene expression.  
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Figure 3.5.1 Immunoblot analysis of HspB8 protein expression in a delayed-labour 
model following administration of progesterone (P4) or corn oil (O; vehicle control) to 
pregnant rats. (A) Representative immunoblots of HspB8 protein and calponin are shown. 
Analysis was performed using a HspB8 specific antibody (LifeSpan BioSciences). (B) 
The relative protein expression of HspB8 was analyzed using densitometric analysis. The 
data were presented as the mean ± SEM of the relative optical density of HspB8 
normalized to the optical density of calponin. Values are from four independent 
experiments. Two-way ANOVA revealed that HspB8 protein expression changed 
significantly between the two treatment groups (p< 0.05; n=4/day). All data indicated 
with symbols are significantly different (paired t-test; p< 0.05). HspB8 protein expression 
at d23-P4 was significantly lower compared to expression at d23-O (*, p< 0.05). O, oil; 
P4, progesterone. Designations 21-O, 22-O, 23-O, 21-P4, 22-P4, 23-P4 represent 
gestational time points in the two treatment groups. (C) Representative immunoblots of 
HspB8 protein and calponin are shown. Analysis was performed using a HspB8 specific 
antibody (Cell Signaling). Results further confirm those received using the other 
commercially available antibody from LifeSpan BioSciences. 
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Figure 3.5.2 Immunoblot analysis of HspB8 protein expression in rat myometrium in a 
preterm labour model, following administration of RU486 or corn oil (vehicle control) to 
pregnant rats. Treatment was administered on d18 and samples were collected on d19 of 
gestation. (A) Representative immunoblots of HspB8 protein and calponin are shown. (B) 
The relative expression of HspB8 was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of HspB8 normalized to 
the optical density of calponin. Values are from four independent experiments. Paired t-
test revealed that HspB8 protein expression changed significantly overall (*, p< 0.05; 
n=4/day). O, Oil (vehicle control); T, RU486. 
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3.5.3 Immunofluorescence Detection of HspB8 Protein 
To determine if the spatial localization of HspB8 protein changed due to RU486 
administration, immunofluorescence detection was conducted. Detection of HspB8 
protein in the circular and longitudinal muscle layers demonstrated that HspB8 was 
primarily localized to the cytoplasm of myometrial cells and that there was an absence of 
nuclear staining in both treatment groups (RU486 or vehicle alone) (Figure 3.5.3). There 
was a notable decrease in HspB8 protein in the circular muscle layer of rat myometrium 
following RU486 administration; however, there was an apparent small increase in the 
level of HspB8 protein in the longitudinal muscle layer following RU486 administration 
(n=2/day). This indicates that there may be myometrial layer-specific up- 
regulation of HspB8 protein expression as a result of functional progesterone withdrawal.  
 
3.5.4 Expression of Bag3 Protein 
 RU486 treated rat myometrial samples were also used to study the effects of 
progesterone on Bag3 protein expression. Immunoblot analysis of Bag3 protein 
expression in myometrial tissue collected from vehicle and RU486-treated rats indicated 
that a functional progesterone withdrawal did not significantly affect Bag3 protein 
expression (p>0.05; n=4/day; Figure 3.5.4). This result suggests that progesterone is not a 
major regulator of Bag3 protein expression.  
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Figure 3.5.3 Immunofluorescence detection of HspB8 protein in the longitudinal and 
circular muscle layers of rat myometrium, using a HspB8 specific antibody (LifeSpan 
BioSciences), following treatment of pregnant rats with RU486 (486) or corn oil (vehicle 
control). Treatment was administered on d18 and samples were collected on d19 of 
gestation. The images demonstrate mainly cytoplasmic localization of HspB8 protein and 
an absence of nuclear staining. There was a notable decrease in HspB8 protein in the 
circular muscle layer and an apparent small increase in HspB8 protein in the longitudinal 
muscle layer, following RU486 administration (n=2/day). Ctrl = control, rabbit IgG. 
Scale bar = 50 µm. 
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Figure 3.5.4 Immunoblot analysis of Bag3 protein in the rat myometrium in a preterm 
labour model, following administration of RU486 or corn oil (vehicle control) to 
pregnant rats. Treatment was administered on d18 and samples were collected on d19 of 
gestation. (A) Representative immunoblots of Bag3 protein and calponin are shown. (B) 
The relative expression of Bag3 was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of Bag3 normalized to 
the optical density of calponin. Values are from four independent experiments. Paired t-
test revealed that Bag3 protein expression did not change significantly overall (p> 0.05; 
n=4/day). O, Oil (vehicle control); T, RU486. 
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3.5.5 Expression of LC3II Protein 
 RU486 treated myometrial samples were also used to study the effects of 
progesterone on LC3II protein expression. Immunoblot analysis of LC3II protein 
expression in myometrial tissue collected from vehicle and RU486-treated rats indicated 
that a functional progesterone withdrawal results in a small, but statistically significant 
increase in LC3II protein expression (p>0.05; n=4/day; Figure 3.5.5).  
3.6 Exogenous Expression of HspB8 in hTERT-HM Cells 
3.6.1 Optimization of Transfection Efficiency of hTERT-HM Cells 
Experiments were conducted in triplicate to optimize the transfection efficiency of 
hTERT-HM cells with expression vectors using an Amaxa Nucleofector system. pEGFP-
C3 expression vector was transiently transfected into hTERT-HM cells using Amaxa 
basic nucleofector kit for primary smooth muscle cells (Lonza). Transfection of the cells 
was conducted using the programs A-033, D-033, P-013, P-042, U-025, B-017 or no 
program (control). Optimization of transfection was repeated with a focus on Lonza 
nucleofector programs A-033 and U-025 as they had the highest transfection efficiency 
and the least amount of cell loss in the initial experiment. Consultation with the company 
Lonza also resulted in the testing of the program B-017 (Figure 3.6.1- 3.6.2). The results 
indicated that Program A-033 had the highest transfection efficiency and the least amount 
of cell loss for hTERT-HM cells. Thus, Program A-033 was utilized for all further 
transfection experiments.  
139 
 
 
 
 
 
Figure 3.5.5 Immunoblot analysis of LC3II protein expression in rat myometrium in a 
preterm labour model, following administration of RU486 or corn oil (vehicle control) to 
pregnant rats. Treatment was administered on d18 and samples were collected on d19 of 
gestation. (A) Representative immunoblots of LC3II protein and calponin are shown. (B) 
The relative expression of LC3II was analyzed using densitometric analysis. The data 
were presented as the mean ± SEM of the relative optical density of LC3II normalized to 
the optical density of calponin. Values are from four independent experiments (n=4/day). 
Paired t-test revealed that LC3II protein expression changed significantly overall (*, p< 
0.05). O, Oil (vehicle control); T, RU486. 
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Figure 3.6.1 Micrographs of hTERT-HM cells 24 h post-transfection with programs A-
033, U-025 and B-017. Images on the left represent phase contrast micrographs 24 h after 
transfection while immunofluorescence micrographs on the right demonstrate the same 
cells that have been transiently transfected with pEGFP-C3 expression vector. Scale bar = 
100 µm. 
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Figure 3.6.2 Micrographs of hTERT-HM cells 48 h post-transfection with programs A-
033, U-025 and B-017. Images on the left represent phase contrast micrographs 48 h after 
transfection while immunofluorescence micrographs on the right indicate cells that have 
been transiently transfected with pEGFP-C3 expression vector 48 h after transfection. 
Scale bar = 100 µm. 
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3.6.2 Transfection of hTERT-HM Cells with pCImycHspB8 Vector 
   Initially hTERT-HM cells were transiently transfected with pEGFP-C3 expression 
vector or co-transfected with pCImycHspB8 and pEGFP-C3 expression vectors. hTERT-
HM cells that were not transfected (No Program) served as a negative control. Seventy 
two hours post-transfection of hTERT-HM cells with pCImycHspB8 expression vector, 
protein lysates were collected and immunoblot analysis was performed using a myc-tag 
specific antibody (Table 2.1). Immunoblot analysis demonstrated that myc-tagged HspB8 
protein was present at ~25 kDa (Figure 3.6.3A). Subsequently, immunoblot analysis was 
performed using an HspB8 specific antibody (Table 2.1). A band was detected at ~22 
kDa, representing endogenous expression of HspB8 protein, and at ~25 kDa representing 
myc-tagged HspB8 protein (Figure 3.6.3B). 
3.6.3 Transfection of hTERT-HM Cells with pCImycBag3 Vector 
   Initially hTERT-HM cells were transiently transfected with pEGFP-C3 expression 
vector or co-transfected with pCImycBag3 and pEGFP-C3 expression vectors. hTERT-
HM cells that were not transfected (No Program) served as a negative control.  Following 
transfection of hTERT-HM cells with pCImycBag3 expression vector, protein lysates 
were collected and immunoblot analysis was performed using a myc-tag specific 
antibody (Table 2.1). Immunoblot analysis demonstrated that myc-tagged Bag3 protein 
was detected at the expected ~74 kDa demonstrating exogenous Bag3 expression (Figure 
3.6.4A). Subsequently, immunoblot analysis was performed using a Bag3 specific  
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Figure 3.6.3(A) Immunoblot analysis of myc-HspB8 expression. Following transfection 
of hTERT-HM cells with pCImycHspB8 expression vector, protein lysates were 
collected and immunoblot analysis was performed using an a myc-tag specific antibody 
(Millipore). Lane 1 represents No program (cells were not transfected), Lane 2 represents 
cells that have been transiently transfected with pEGFP-C3 expression vector and Lane 3 
represents cells that have been transiently transfected with pCImycHspB8 expression 
vector. Following immunoblot analysis a band is detected in lane 3 at ~25 kDa indicating 
the presence of myc-tagged HspB8, suggesting that the transfection was successful. (B) 
Following immunoblot analysis using a HspB8 specific antibody, a band is detected in 
lanes 1 2 and 3 at ~22 kDa, representing endogenous expression of HspB8 protein. In 
lane 3 a band is also detected at ~25 kDa representing myc-tagged HspB8 protein.  
 
  
20 kDa
25 kDa
37 kDa
50 kDa
My
c-H
spB
8
GF
P
No
 pr
ogr
am
B
20 kDa
25 kDa
37 kDa
50 kDa
My
c-H
spB
8
GF
P
No
 pr
ogr
am
IB: Myc-tag IB: HspB8
A
147
148 
 
 
 
 
 
Figure 3.6.4 Immunoblot analysis of myc-Bag3 expression in hTERT-HM cells. 
Following transient transfection of hTERT-HM cells with pCImycBag3 expression 
vector, protein lysates were collected and immunoblot analysis was performed using a 
myc-tag specific antibody (Millipore). Lane 1 represents No program (cells were not 
transfected), Lane 2 represents cells that have been transiently transfected with pEGFP-
C3 expression vector and Lane 3 represents cells that have been transiently transfected 
with pCImycBag3 expression vector. (A) Following immunoblot analysis a band is 
detected in lane 3 at ~74 kDa indicating the presence of myc-tagged Bag3 protein, 
suggesting that the transfection was successful. (B) Following immunoblot analysis, 
using a Bag3 specific antibody, a band is detected in lanes 1 2 at ~74 kDa, representing 
endogenous expression of Bag3 protein. In lane 3 a band is also detected at ~74 kDa, 
representing both endogenous expression of Bag3 protein and myc-tagged Bag3 protein. 
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antibody (Table 2.1). A band was detected at ~74 kDa representing endogenous 
expression of Bag3 protein (Figure 3.6.4B).  
3.6.4 Transfection of hTERT-HM Cells with pCImycHspB8, pCImycBag3 and pEGFP-C3 
Vectors 
   Initially hTERT-HM cells were transiently transfected with pEGFP-C3 expression 
vector or co-transfected with pEGFP-C3, pCImycHspB8, and pCImycBag3 expression 
vectors. hTERT-HM cells that were not transfected (No Program) served as a negative 
control. Seventy-two hours following transfection of hTERT-HM cells with expression 
vectors, protein lysates were collected and immunoblot analyses were performed using 
myc-tag specific antisera (Table 2.1). Immunoblot analysis demonstrated that myc-tagged 
HspB8 protein and myc-tagged Bag3 protein were present as described in sections 3.6.4 
and 3.6.5 (Figure 3.7.5A). Subsequently, immunoblot analysis was performed using an 
HspB8 specific antibody or a Bag3 specific antibody (Table 2.1). Appropriate proteins 
were detected (Figure 3.7.5 B, C) as described previously in sections 3.6.4 and 3.6.5. 
3.6.5 Protein/DNA ratios and Flow Cytometric Analysis of Transfected hTERT-HM Cells 
Protein/DNA ratios were calculated using an RNA/DNA/Protein Purification Kit. 
Following isolation of proteins and purification of genomic DNA no significant increase 
in the protein to DNA ratio was found to occur following transfection of hTERT-HM 
cells with expression vectors (Table 3.1). In order to further assess any exogenous 
protein-induced hypertrophy in hTERT-HM cells, flow cytometric analysis was  
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Figure 3.6.5 Immunoblot analysis of myc-HspB8 and myc- Bag3 in co-transfected 
hTERT-HM cells. Following transient transfection of hTERT-HM cells with 
pCImycHspB8, pCImycBag3 and pEGFP-C3 expression vectors, protein lysates were 
collected and immunoblot analysis was performed using a myc-tag specific antibody 
(Millipore). (A) Lane 1 represents No program (cells were not transfected), Lane 2 
represents cells that have been transiently transfected with pEGFP-C3 expression vector 
and Lane 3 represents cells that have been transiently co-transfected with pCImycHspB8 
and pCImycBag3 expression vectors. Following immunoblot analysis two bands are 
detected in lane 3 at ~75 kDa and ~25 kDa indicating the presence of myc-tagged Bag3 
protein and myc-tagged HspB8 protein respectively, signifying that the transfection was 
successful. (B) Following immunoblot analysis, using a HspB8 specific antibody, a band 
is detected in lanes 1 2 and 3 at ~22 kDa, representing endogenous expression of HspB8 
protein. In lane 3 a band is also detected at ~25 kDa, representing myc-tagged HspB8 
protein. (C) Following immunoblot analysis, using a Bag3 specific antibody, a band is 
detected in lanes 1 2 at ~74 kDa, representing endogenous expression of Bag3 protein. In 
lane 3 a band is also detected at ~74 kDa, representing myc-tagged Bag3 protein. 
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Table 3.1 Protein/DNA ratios of transfected hTERT-HM cells. 
hTERT-HM, Human Telomerase Reverse Transcriptase- Human Myometrial Cells 
 
Sample ID [DNA] µg/µl 
[Protein] 
µg/µl [Protein]/[DNA] 
Average 
(1&2) 
No Program 1 0.22335 1.61 7.21 4.68 No Program 2 0.63503 1.36 2.14 
pEGFP-C3 1 0.29311 0.77 2.63 3.29 pEGFP-C3 2 0.22297 0.88 3.95 
pCImycHspB8 1 0.31706 0.83 2.62 2.68 pCImycHspB8 2 0.30825 0.84 2.73 
pCImycBag3 1 0.25737 0.76 2.95 2.74 pCImycBag3 2 0.26203 0.92 3.51 
pCImycHspB8/Bag3 1 0.31982 0.81 2.53 2.57 pCImycHspB8/Bag3 2 0.28701 0.75 2.61 
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performed. hTERT-HM cells were transiently transfected with pEGFP-C3 expression 
vector or co-transfected with pCImycHspB8 and pEGFP-C3 expression vectors as 
previously described. Following transfections all cells were labeled with far-red 
fluorescent reactive dye (Cy5) using a LIVE/DEAD® Fixable Dead Cell Stain Kit 
(Invitrogen, Burlington, ON, Canada). Subsequently, hTERT-HM cells were analyzed 
using a BD FACSCalibur™ flow cytometer. hTERT-HM cells were gated on the basis of 
forward scatter (FSC) and side scatter (SSC) and cy5 and GFP positivity, respectively 
(Figure 3.6.6A-C and D-F). hTERT-HM cells labeled with both Cy5 and GFP were 
compared to those labeled with only Cy5, using a gating strategy. Double-labeled cells 
appear in the upper right quadrant of the bivariate correlation plot (Figure 3.6.6 D-F). 
Forward scatter analysis was then used as an indicator of cell size, as shown in the graph 
representing an overlay of No Program Control (Cy5), pEGFP-C3 (Cy5), pEGFP-  
C3 (Cy5/GFP), pCImycHspB8/pEGFP-C3 (Cy5) and pCImycHspB8/ pEGFP-C3 
(Cy5/GFP) (Figure 3.6.6G). As there was little variance in the forward scatter, transient 
transfection of hTERT-HM cells with pCImycHspB8 expression vector was not  
sufficient to induce cellular hypertrophy. Flow cytometric analysis was then repeated, in 
a similar manner, for hTERT-HM cells that had been co-transfected with pCImycBag3 
and pEGFP-C3 expression vector or pCImycHspB8, pCImycBag3 and pEGFP-C3 
expression vectors. hTERT-HM cells were again gated on the basis of forward scatter 
(FSC) and side scatter (SSC) and cy5 and GFP positivity, respectively (Figure 3.6.7A-C, 
Figure 3.6.8A-C; Figure 3.6.7D-F, Figure 3.6.8D-F). Subsequently, forward scatter 
analysis was used as an indicator of cell size, as shown in the graph representing an  
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Figure 3.6.6 Flow cytometric analysis of hTERT-HM cells transiently transfected with 
pEGFP-C3 expression vector or co-transfected with pCImycHspB8 and pEGFP-C3 
expression vectors. hTERT-HM cells were gated on the basis of forward scatter (FSC) 
and side scatter (SSC) (A-C) and cy5 and GFP positivity (D-F). hTERT-HM cells labeled 
with both Cy5 and GFP were compared to those labeled with only Cy5, using a gating 
strategy. Double-labeled cells appear in the upper right quadrant of the bivariate 
correlation plot (D-F). FSC analysis was used as an indicator of cell size as shown in the 
graph, which represents an overlay of No Program Control (Cy5), pEGFPC-3 (Cy5), 
pEGFP-C3 (Cy5/GFP), pCImycHspB8/pEGFP-C3 (Cy5) and pCImycHspB8/ pEGFP-C3 
(Cy5/GFP) (G).  
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Figure 3.6.7 Flow cytometric analysis of hTERT-HM cells transiently transfected with 
pEGFP-C3 expression vector or co-transfected with pCImycBag3 and pEGFP-C3 
expression vectors. hTERT-HM cells were gated on the basis of forward scatter (FSC) 
and side scatter (SSC) (A-C) and cy5 and GFP positivity (D-F). hTERT-HM cells labeled 
with both Cy5 and GFP were compared to those labeled with only Cy5, using a gating 
strategy. Double-labeled cells appear in the upper right quadrant of the bivariate 
correlation plot (D-F). FSC analysis was used as an indicator of cell size as shown in the 
graph, which represents an overlay of No Program Control (Cy5), pEGFPC-3 (Cy5), 
pEGFP-C3 (Cy5/GFP), pCImycBag3/pEGFP-C3 (Cy5) and pCImycBag3/ pEGFP-C3 
(Cy5/GFP) (G).  
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Figure 3.6.8 Flow cytometric analysis of hTERT-HM cells transiently transfected with 
pEGFP-C3 expression vector or co-transfected with pCImycHspB8, pCImycBag3 and 
pEGFP-C3 expression vectors. hTERT-HM cells were gated on the basis of forward 
scatter (FSC) and side scatter (SSC) (A-C) and cy5 and GFP positivity (D-F). hTERT-
HM cells labeled with both Cy5 and GFP were compared to those labeled with only Cy5, 
using a gating strategy. Double-labeled cells appear in the upper right quadrant of the 
bivariate correlation plot (D-F). FSC analysis was used as an indicator of cell size as 
shown in the graph, which represents an overlay of No Program Control (Cy5), pEGFPC-
3 (Cy5), pEGFP-C3 (Cy5/GFP), pCImycHspB8/pCImycBag3/pEGFP-C3 (Cy5) and 
pCImycHspB8/pCImycBag3/pEGFP-C3 (Cy5/GFP) (G).  
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overlay of all hTERT-HM cells being analyzed (Figure 3.6.7G, Figure 3.6.8G). Once 
again transient transfection of hTERT-HM cells, with pCImycBag3 or pCImycHspB8 
and pCImycBag3 expression vectors, was not sufficient to induce cellular hypertrophy. 
3.7 Expression of HspB8 in hTERT-HM Cells Following Ang II Treatment 
  hTERT-HM cells were administered 1000 nM of Ang II for 72 h as described in 
section 2.6.3. Observation of hTERT-HM cells following 72 h of Ang II administration 
indicated that there was no visible increase in cell size (Figure 3.7.1- 3.7.2). Immunoblot 
analysis was then performed to determine if Ang II administration had any effect on 
HspB8 or Bag3 protein expression. Seventy two hours of Ang II administration to 
hTERT-HM cells did not significantly increase HspB8 or Bag3 protein expression 
(Figure 3.7.3). Protein/DNA ratios were calculated using an RNA/DNA/Protein 
Purification Kit as described in section 2.8. Following isolation of proteins and 
purification of genomic DNA there was no significant increase in the protein to DNA 
ratio of hTERT-HM cells following Ang II administration (Table 3.2). To fully assess 
hypertrophy in hTERT-HM cells following Ang-II administration, flow cytometric 
analysis was performed following 72 h of Ang II (1000 nM) administration. hTERT-HM 
cells were gated on the basis of forward scatter (FSC) and side scatter (SSC) and SSC and 
cy5 positivity (Figure 3.7.4A,B). FSC analysis was used as an indicator of cell size which 
represents an overlay of hTERT-HM control cells (0 nM Ang II) and hTERT-HM cells 
administered 1000 nM Ang II (Figure 3.7.4C). There was little variance in the FSC 
suggesting that Ang II administration was not sufficient to induce cellular hypertrophy of  
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Figure 3.7.1 Representative images from phase contrast micrographs of hTERT-HM 
cells following administration of Ang II (1000 nM). Images on the left represent hTERT-
HM control cells that were not administered Ang II. Images on the right represent 
hTERT-HM cells that were administered Ang II for 24, 48 or 72 h. Scale bar = 100 µm. 
Ang II = Angiotensin II. 
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Figure 3.7.2 Magnification of representative images from phase contrast micrographs of 
hTERT-HM cells following administration of Ang II (1000 nM). The image on the top 
represents control cells that were not administered Ang II, after 48 h. The image on the 
bottom represents cells administered 1000 nM Ang II for 48 h. Scale bar = 100 µm. Ang 
II = Angiotensin II. 
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Figure 3.7.3 Immunoblot analysis of HspB8, Bag3 and GAPDH in hTERT-HM cells 
following Ang II (0 nM versus 1000 nM) administration for 72 h. Representative 
immunoblots are shown. Analysis was performed using HspB8 and Bag3 specific 
antibodies (Dr. Jacques Landry). Ang II= Angiotensin II. 
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Table 3.2 Protein/DNA ratios of hTERT-HM cells following Ang II administration. 
 
hTERT-HM, Human Telomerase Reverse Transcriptase- Human Myometrial Cells; Ang 
II, Angiotensin II 	  
Sample ID [DNA] µg/µl 
[Protein] 
µg/µl [Protein]/[DNA] 
Average  
(1&2) 
0 nM Ang II 1 0.13083 0.64 4.89 4.62 0 nM Ang II 2 0.17527 0.76 4.34 
1000 nM AngII 
1 0.12673 0.71 5.60 4.67 1000 nM AngII 
2 0.20078 0.75 3.74 
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Figure 3.7.4 Flow cytometric analysis of hTERT-HM cells following 72 h of Ang II 
(1000 nM) administration. hTERT-HM cells were gated on the basis of forward scatter 
(FSC) and side scatter (SSC) and SSC and cy5 positivity (A, B). FSC analysis was used 
as an indicator of cell size as shown in the graph, which represents an overlay of hTERT-
HM control cells (0 nM Ang II) and hTERT-HM cells administered 1000 nM Ang II (C). 
Ang II = Angiotensin II. 
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hTERT-HM cells within the timeframe utilized in the experiments.  
3.8 Assessment of HspB8 and Bag3 Protein Association in Myometrial Cell and 
Tissue Lysates by Immunoprecipitation 
 Utilizing HeLa (human cervical cancer) and COS-1 (African green monkey 
kidney) cells, Carra et al. (2008) have suggested a new chaperone complex that is 
comprised of HspB8 and Bag3 proteins [236]. To determine the interaction, if any, 
between HspB8 and Bag3 in uterine smooth muscle, IP experiments were conducted on 
hTERT-HM protein lysates, as well as myometrial tissue homogenates from NP, d15, and 
d23 of rat pregnancy. IP of HspB8 protein, myc-tagged HspB8 protein and Bag3 protein 
in hTERT-HM cells was followed by immunoblot analysis using HspB8, Bag3, and myc-
specific antibodies (Table 2.1). HspB8 protein was detected at ~22 kDa in all three pull 
downs (Figure 3.8.1A). It is important to note that IP of myc-tagged HspB8 protein 
resulted in detection of HspB8 protein at a slightly higher molecular weight due to the 
added myc tag. Conversely, after IP of HspB8, myc-HspB8 and Bag3 proteins and 
subsequent immunoblot analysis with a Bag3 specific antibody, Bag3 protein was 
detected at ~74 kDa in all three pull downs (Figure 3.8.1B). These results suggested that 
HspB8 and Bag3 are interacting with one another to form a complex in hTERT-HM cells.  
To confirm whether HspB8 and Bag3 were interacting in vivo, IP experiments 
were conducted on myometrial tissue homogenates from the following time points: NP, 
d15 and d23 of rat pregnancy. IP of HspB8 or Bag3 in tissue lysates was followed by 
immunoblot analysis using HspB8 and Bag3 specific antibodies (Table 2.1). After IP and 
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Figure 3.8.1 Immunoprecipitation (IP) and immunoblot analyses (IB) of HspB8, myc-
tagged HspB8 and Bag3 proteins in hTERT-HM cells. (A) Lane 1, input, represents a 
hTERT-HM lysate (1/10th), lane 2 represents IP of HspB8 protein, lane 3 represents IP of 
myc-tagged HspB8 protein, lane 4 represents IP of Bag3 protein and lane 5 represents IP 
with Rabbit IgG (control). Figure A indicates that following IP there was detection of 
HspB8 protein at ~22 kDa or myc-tagged HspB8 protein at ~25 kDa. (B) Conversely, 
Figure B indicates that following IP there was detection of Bag3 at ~74 kDa. These 
results demonstrate that HspB8 and Bag3 form a complex in hTERT-HM cells. 
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subsequent immunoblot analysis, Bag3 protein was detected at ~74 kDa in all HspB8 and 
Bag3 pull downs (Figure 3.8.2A). After IP and immunoblot analysis, HspB8 protein was 
also detected at ~22 kDa in all HspB8 and Bag3 pull downs (Figure 3.8.2B). Together 
these results demonstrated that HspB8 and Bag3 were associating with one another in 
vitro and in vivo.  
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Figure 3.8.2 Immunoprecipitation (IP) and immunoblot analysis (IB) of HspB8 and Bag3 
proteins in rat myometrial tissue lysates (NP, d15, d23). Following IP there was detection 
of HspB8 protein at ~22 kDa and Bag3 protein at ~74 kDa at all three gestational time 
points (n=3/day). These results demonstrate that HspB8 and Bag3 form a complex in rat 
myometrium during pregnancy. 
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Chapter Four 
Discussion 
4.1 Analysis of HspB8 and Bag3 Protein Expression in Myometrium during 
Pregnancy and Labour 
 Our lab previously reported that HspB8 mRNA levels were initially low and then 
expression began to increase significantly between d17 and PP (with the exception of 
d22) [237]. We therefore hypothesized that HspB8 protein expression would be elevated 
towards mid-pregnancy. In this study, HspB8 protein expression was significantly 
elevated at d15, d17 and d19 compared to NP and d6 time points. 
Significantly increased HspB8 protein expression beginning at d15 of gestation 
was in contrast to the observed significant increase in HspB8 mRNA expression 
beginning at d17. As mRNA is normally translated to form protein a greater correlation 
of mRNA and HspB8 expression was expected. It is possible that there was sufficient 
mRNA available for protein translation during early pregnancy and that the increased 
HspB8 mRNA expression at d17 and later reflects a need for increased HspB8 
translation. Furthermore, the variation in gestational timing when tissues were collected 
(± 12 hours) may serve as a small contributing factor to the poor correlation in mRNA 
and protein expression. As both HspB8 mRNA and protein expression began to increase 
after mid-gestation, our results indicate that HspB8 may play an important role during 
this time in pregnancy. 
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 Immunoblot analysis was also performed to determine the expression pattern for 
Bag3 protein in pregnant rat myometrium. Bag3 protein expression was significantly 
elevated at d15, compared to expression at NP, and at d17 compared NP, d6, d23 and PP. 
During immunoblot analysis, it was noted that in addition to the band representing full-
length Bag3 protein (~74 kDa), other bands (~40kDa/~25kDa) were detected 
representing possible cleavage products of Bag3. A smaller form of Bag3 (~40 kDa), in 
neural synaptosomes homogenates, has been analyzed by IP and mass spectrometry 
[210]. Furthermore, published reports indicate that Bag3 is cleaved during apoptosis. 
Bag3 is efficiently cleaved by caspase-3, to a smaller extent by caspases-1 and -8, and 
relatively inefficiently by caspase-9 [238]. More specifically, caspase-3 is able to cleave 
Bag3 into 2 smaller fragments in pancreatic cancer cells resulting in products of ~40 kDa 
and ~25 kDa similar to results presented in this thesis [238, 239]. As it is known that 
caspase-3 is up-regulated between the proliferative and synthetic phase of myometrial 
differentiation [41], the ~40 kDa and ~25 kDa bands recognized by the Bag3 antibody 
may be cleavage products of Bag3. 
 The up-regulation of HspB8 and Bag3 at mid-gestation coincides with the 
differentiation of the myometrium from a state of hyperplasia to hypertrophy (Figure 
4.1A). As they show similar patterns of expression this suggests that they may interact or 
play similar roles during pregnancy.  
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Figure 4.1 Representative patterns of HspB8 and Bag3 protein expression during the 
phases of myometrial differentiation. (A) HspB8 protein expression (black curve) was 
found to be significantly elevated at d15, d17 and d19 compared to NP and d6. Bag3 
protein expression (red curve) was significantly elevated at d15, compared to expression 
at NP, and at d17 compared to NP, d6, d23 and PP. The up-regulation of HspB8 and 
Bag3 proteins coincides with differentiation of the myometrium from a state of 
hyperplasia to hypertrophy (B) Hsp70 protein expression (yellow curve) was significantly 
elevated at d19, d21, d22 and d23 compared to NP and d6. Hsc70 protein and CHIP (dark 
blue curve) are constitutively expressed. LC3II protein expression (teal curve) was found 
to be significantly elevated at PP compared to expression at NP, d6 and d12.  
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4.2 Intracellular Localization of HspB8 and Bag3 Proteins in the Myometrium 
during Pregnancy	  
This is the first report of the intracellular localization of HspB8 and Bag3 in the 
myometrium. The spatiotemporal expression of HspB8 and Bag3 in pregnant rat 
myometrium was determined in situ using rat uterine tissue samples and 
immunofluorescence microscopy. HspB8 was predominantly localized to the cytoplasm 
of cells and there was an absence of nuclear staining. This is consistent with previous 
research on extracts of estrogen receptor-positive breast cancer cells using size-exclusion 
chromatography, indicating that HspB8 was detected primarily in the cell cytoplasm 
[240]. HspB8 was also detected near cell membranes in the rat myometrium. This 
specific cellular localization has also been shown in a human neuroblastoma cell line, 
SK-N-SH [241]. There was intense cytoplasmic staining, particularly on d15, indicating 
concentrated subcellular localization of HspB8 protein. HspB8 has been found to 
colocalize with aggregates formed by misfolded or partially denatured proteins. For 
instance, HspB8 can be trapped within inclusions formed by proteins with polyglutamine 
tails (Htt43Q) in order to prevent the formation of large aggregates [178]. HspB8 has also 
been found in aggregates formed by αB-crystallin mutants, which are involved in 
myofibrillar myopathy [242]. Thus, HspB8 may be responsible for preventing 
aggregation or promoting degradation of misfolded proteins, which may result in 
concentrated subcellular localization.   
The intracellular localization of Bag3 protein was also examined. There was an 
absence of nuclear staining, as well as some perinuclear localization of Bag3 along with 
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the general cytoplasmic localization in myometrial cells. Previous research on HeLa cells 
indicates that when the cells were exposed to cadmium, zinc or to 42°C, the localization 
of Bag3 changed to a reticular, perinuclear localization on a cytosolic background. More 
specifically, co-immunofluorescence experiments demonstrated calreticulin, a protein 
resident in the rough endoplasmic reticulum (ER), co-localized with Bag3 protein in 
cadmium-treated HeLa cells [243]. Reticular, perinuclear localization of Bag3 may have 
a role(s) in the myometrium throughout gestation. The ER is known to be a major point 
of integration of damage-sensing or pro-apoptotic stimuli [244]. Even though Bag3 lacks 
an ER localization signal, it is probable that Bag3 is required in the ER to complex with 
other proteins, as interactions with different proteins play an important role in 
determining the function of Bag3 [245]. Bag3 is capable of interacting with Bcl2, for 
instance, which can result in increased anti-apoptotic activity and a decrease in the 
apoptosis induced via Bax or Fas in HeLa cells [246]. Alternatively, Bag3 may form a 
large multichaperone complex consisting of HspB8-Bag3-Hsp70/Hsc70-CHIP, as a 
means to regulate the degradation of misfolded proteins through the stimulation of the 
macroautophagy pathway [183, 184, 200, 202, 208]. 
Localization of both HspB8 and Bag3 proteins in the cytoplasm of the 
myometrium is consistent with their aggregations in this compartment and with reports 
showing an interaction between the two proteins [183]. 
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4.3 Role of HspB8 and Bag3 as Regulators of Apoptosis 
 There are three major processes that help to maintain homeostasis of the 
myometrium throughout gestation: proliferation, differentiation and apoptosis. Apoptosis, 
also known as programmed cell death, is responsible for eliminating dysfunctional cells 
during development or normal tissue homeostasis. The process of apoptosis can be 
activated via two different pathways: the extrinsic and the intrinsic pathway. Both 
pathways result in activation of a caspase cascade and the effector, caspase-3. Caspase-3 
activation is associated with cleavage of cellular substrates that ultimately results in cell 
death, but it also reduces myocyte contractility in smooth muscle [247, 248]. Caspase-3 
in the myometrium is also hypothesized to act as an anti-contractile agent that is activated 
around d14, between the phases of myometrial hyperplasia and hypertrophy, to help 
maintain uterine quiescence [41]. At this time, Shynlova et al. (2006) found that there 
was also a notable increase in the expression of two anti-apoptotic regulating proteins, 
Bcl2 and Bcl2l1, and as a result there were no physiological manifestations of apoptosis 
in the myometrial cells [18].  
 In this study, the up-regulation of HspB8, at d15, d17 and d19, coincides with the 
increase in expression of caspase-3, as the myometrium differentiates from a state of 
hyperplasia to hypertrophy (Figure 4.1) [41]. HspB8 acts as a regulator of apoptosis and 
therefore it is possible that HspB8 may play such a role during this transition period [249-
252]. Depre et al. (2006) found that HspB8 was able to protect the myocardium against 
apoptosis by binding to PKB and AMPK, resulting in stimulation of survival mechanisms 
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in both the cytosol and nucleus [234]. This included inhibition of pro-apoptotic effectors, 
such as Bad, FOXO and glycogen synthase kinase-3β. Similarly, treatment of human 
breast cancer cell line MCF-7 with 17β-estradiol elevates HspB8 protein expression, and 
protects breast cancer cells from apoptosis [249]. HspB8 is also overexpressed in 
stomach tumors, proliferating human keratinocytes, and rat pheochromocytoma (PC12) 
cells, once again demonstrating anti-apoptotic properties [253].  
 Bag3 also serves as an anti-apoptotic effector. In several published reports Bag3 
silencing or overexpression caused enhanced or inhibited spontaneous or drug-induced 
apoptosis, respectively [188, 192, 254-261]. For example, in 293 cells transfected with a 
Bag3-hyperexpressing construct, apoptosis induced by the glutathione-depriving agent 
diethylmaleate (DEM) + 2-methyoxymethylestradiol (2-ME) was 60 % lower when 
compared to control cultures. Similarly, in human myeloid U937 cells, a decrease in 
Bag3 protein levels by a phosphorothioate antisense oligodeoxynucleotide increased cell 
apoptotic response to DEM by 40 % [262].  
In total, HspB8 as well as Bag3 may play important anti-apoptotic roles by 
promoting cell survival in the rat myometrium near the window of d12-d15 gestation. 
Ultimately, more research must be conducted in this area to further confirm the role of 
HspB8 and Bag3 as anti-apoptotic proteins in smooth muscle, particularly in the 
transition from hyperplasia to hypertrophy. Furthermore, there have been some 
contrasting data suggesting HspB8 may have a role in promoting apoptosis. In one 
experiment performed by Gober et al. (2003) treatment of the tumour cell lines SK-MEL-
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2 (melanoma) and PC-3 (prostate cancer) with the demethylating agent 5-aza-2’-
deoxycytidine to induce HspB8 expression, transient transfection with HspB8 expression 
vectors, or retrovirus-mediated delivery of HspB8 resulted in caspase- and p38MAPK- 
dependent apoptosis [250]. 
4.4 Role of HspB8 and Bag3 as Regulators of Macroautophagy 
Following IP experiments, immunoblot analysis indicated that HspB8 and Bag3 
interacted with one another in vitro in hTERT-HM cells and in vivo in rat myometrium 
during pregnancy. Given that complexing of sHsps is essential for their function, it is 
plausible that the interaction between HspB8 and Bag3 may be important throughout 
pregnancy [123]. sHsps have been found to play key roles in proteostasis, which involves 
modulation of concentration, structure, interactions and cellular localization of proteins. 
Recently, it was reported that muscle tissue relies on an effective proteostasis network in 
which macroautophagy is a critical component [208]. The up-regulation of HspB8 and 
Bag3 just after mid-gestation, as shown by immunoblot analysis, coincides with the 
differentiation of the myometrium from a state of hyperplasia to hypertrophy. This 
transition is associated with significant protein turnover and thus alternative to a role in 
regulating apoptosis. HspB8, Bag3 and a regulatory pathway such as macroautophagy 
may be required to help maintain protein homeostasis in the myometrium during 
pregnancy.  
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The basal level of macroautophagy is a critical regulator of cellular homeostasis 
as it is responsible for the removal of damaged/old organelles (particularly mitochondria), 
protein aggregates, and the turnover of long-lived proteins [93, 107]. Bag3, like all Bag 
family members, is capable of interacting with Hsp70/Hsc70 via its Bag domain, which 
subsequently interacts with a well-known Hsp70/Hsc70 binding co-factor- the ubiquitin 
ligase CHIP. Several recent studies showed that the multichaperone complex, HspB8-
Bag3-Hsp70/Hsc70-CHIP, was able to regulate the degradation of misfolded proteins, 
such as polyQ-expanded huntingtin and mutant SOD1, through the stimulation of the 
macroautophagy pathway [183, 184, 200, 202, 208]. Detection of Hsp70, Hsc70 and 
CHIP proteins, by immunoblot analysis, indicates that some of the key players involved 
in the stimulation of the macroautophagy pathway are present in uterine musculature 
throughout gestation (Figure 4.1B). Thus far, the only known marker for autophagosome 
formation in the macroautophagy pathway is LC3II and therefore detection of LC3II 
protein, by immunoblot analysis, in the myometrium throughout gestation supports the 
notion that macroautophagy may serve as an important homeostatic process during this 
period to help maintain pregnancy [216, 217]. The autophagosome, however, is an 
intermediate structure in the dynamic process of macroautophagy and thus, the presence 
of LC3II in the myometrium does not definitively indicate whether this is due to 
macroautophagy induction or suppression of the pathway downstream of the 
autophagosome [218].  
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As overexpression of HspB8 and Bag3 stimulates phosphorylation of eIF2α, 
resulting in activation of the macroautophagy machinery, Pser51-eIF2α protein 
expression was analyzed in rat myometrium throughout gestation [185]. Pser51-eIF2α 
expression did not increase significantly throughout gestation. This suggests that the up-
regulation of HspB8 and Bag3 during mid-gestation, in rat myometrium, is not likely 
responsible for translational shutdown and subsequent stimulation of the macroautophagy 
machinery through eIF2α. 
4.5 The Effect of Distension on HspB8 Protein Expression  
 Uterine stretch, as a result of growing pups, is an important inducer of gene 
expression in uterine muscle. As increased expression of HspB8 protein in the 
myometrium coincided with a time of increasing distension it was important to determine 
whether uterine distension had any regulatory effect on HspB8 expression. Virgin female 
rats underwent unilateral tubal ligation, through a flank incision, and as a result the rat 
was only able to implant the conceptus in one horn. This procedure isolates the influence 
of stretch while maintaining a consistent endocrinological environment, except for any 
local factors secreted by the placenta or fetus [51]. Tissue samples from three different 
time points in pregnancy, d15, d19 and d23, were examined to determine if uterine 
distension had an effect on HspB8 protein expression. Unexpectedly, immunoblot 
analysis revealed that expression of HspB8 protein was not differentially influenced by 
stretch. Furthermore, immunofluorescence detection demonstrated that there was mainly 
cytoplasmic localization of HspB8 in myometrial cells, as well as detection near cell 
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membranes, but there were no marked changes in the expression of HspB8 protein in the 
gravid uterine horn when compared to the non-gravid horn. Therefore, uterine stretch 
does not appear to play a regulatory role in the expression of HspB8 protein. This is in 
contrast to work by White & MacPhee that demonstrated another Hsp, HspB1 was 
regulated by uterine stretch. In unilaterally pregnant rats, HspB1 mRNA and pSer15-
HspB1 protein expression were significantly elevated in distended gravid uterine horns at 
both d19 and d23 (labour) or gestation compared to non-gravid horns. Both HspB1 
mRNA and pSer15-HspB1 protein expression were also markedly increased in 
ovariectomized, NP rat myometrium distended for 24 h with laminaria tents compared to 
empty horns [223].  
4.6  The Effect of Progesterone on HspB8 Protein Expression and RU486 on HspB8, 
Bag3 and LC3II Protein Expression 
 The circulating levels of progesterone in rat maternal serum peak specifically 
between d15-d19 after which there is a dramatic decline until labour [49]. The peak 
levels coincide with the noted increase in Bag3 and HspB8 protein levels, suggesting that 
progesterone may play a role in regulating Bag3 and HspB8 protein expression in rat 
myometrium. Administration of progesterone to pregnant rats (beginning on d20) did not 
change HspB8 protein expression until d23, at which point expression significantly 
decreased. It is unknown whether or not this decrease in HspB8 protein expression is due 
to the effects of prolonged progesterone levels or an increased stress that is incurred as a 
result of prolonging labour. In order to further analyze the role of progesterone on HspB8 
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protein expression in rat myometrium RU486, a progesterone receptor antagonist, was 
administered to pregnant rats on d18 of gestation. This treatment resulted in preterm 
delivery of the pups within 24 h as previously reported [263]. Progesterone receptor 
antagonism resulted in a significant increase in HspB8 protein expression, as well as a 
change in the spatial localization of this protein within myometrial cells. Following 
treatment of RU486 there was a marked decrease in the detection of HspB8 in the 
circular muscle layer; however, there was a marked increase in detection in the 
longitudinal muscle layer. This indicates that there may be myometrial layer-specific 
regulation of HspB8 expression as a result of functional withdrawal of progesterone. As 
Bag3 protein expression followed a similar pattern to HspB8 it was important to see if 
Bag3 expression was regulated by progesterone. In RU486-administration experiments 
there was no change in Bag3 protein expression suggesting that progesterone was not a 
major regulator of Bag3 expression. 
 As HspB8 protein regulation by progesterone appears to be complex, it was 
important to analyze LC3II protein expression following RU486 treatment to determine if 
RU486 had additional effects on myometrial function. Progesterone receptor antagonism 
by RU486 induced preterm labour and resulted in a significant increase in LC3II protein 
expression, indicating that there was a potential increase in the requirement for 
macroautophagy machinery to maintain protein homeostasis. Therefore, it is unclear 
whether the change in HspB8 protein expression observed upon RU486 administration 
and preterm birth is a result of the functional withdrawal of progesterone or the 
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requirements for preterm delivery. It is probable that the side effects of preterm labour, 
such as increased macroautophagy, may have indirectly led to our observed results. Thus, 
the role of progesterone in regulating HspB8 protein expression in the myometrium still 
remains to be fully clarified. 
4.7 Myometrial Cell Model of Hypertrophy 
Adenoviral-mediated overexpression of HspB8 in neonatal rat cardiac myocytes 
results in cell hypertrophy within 48 h of expression, as shown by an increase in the 
protein/DNA ratio by 37% [172]. Therefore, the hTERT-HM cell line was used to help 
assess the importance of HspB8 and other chaperone machine components in myometrial 
hypertrophy. In order to determine whether HspB8 and/or Bag3 was capable of inducing 
myometrial hypertrophy, pCImycHspB8 and/or pCImycBag3 expression vectors were 
transiently transfected into hTERT-HM cells. Exogenous HspB8 or Bag3 protein 
expression was verified by immunoblot analysis using a myc-tag specific antibody. Cells 
did not appear to increase in cell size when viewed with a Leica DMIRE2 inverted 
microscope equipped with phase contrast optics. Thus, potential hypertrophy of 
transfected hTERT-HM cells was further assessed by flow cytometry and determination 
of protein/DNA ratios. There was no change in cell size between transfected cells and 
control cells and there was no significant increase in protein/DNA ratios between the two 
cell populations. These results suggest that overexpression of HspB8 and/or Bag3 alone 
are not sufficient to induce hTERT-HM cell hypertrophy and may require additional 
protein partners or cell-ECM interactions.  
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 Concentrations of Ang II have been found to increase 4.5-fold over the non-
pregnant level in pregnant sheep [264]. In humans the Ang II level was reported to be 
700 nM in maternal circulation during pregnancy [265]. Thus, Cui et al. (2010) examined 
whether Ang II could induce myometrial protein synthesis in a uterine smooth muscle 
tumor derived cell line (ULTR) [266]. They reported that Ang II was able to induce 
cellular hypertrophy, as determined by 3H-leucine incorporation [266]. To determine if 
Ang II could also induce cellular hypertrophy in hTERT-HM cells, protein/DNA ratios 
were calculated and flow cytometry was performed. There was no change in cell size or 
significant increase in protein/DNA ratios between the two treatment groups. Following 
Ang II administration to hTERT-HM cells, HspB8 and Bag3 protein expression was also 
assessed by immunoblot analysis. Ang II administration had no effect on their protein 
expression. Thus, Ang II is not sufficient for inducing myometrial hypertrophy in 
hTERT-HM cells at the concentration and conditions tested.   
4.8 Future Research 
 The results of this investigation provide valuable insights into the formation of a 
heteromeric complex between HspB8 and Bag3 in uterine musculature. The patterns of 
expression of HspB8 and Bag3 in the myometrium indicate that they could have 
important roles during initiation of myometrial hypertrophy and add to the body of 
knowledge indicating sHsps are uniquely expressed with myometrial programming 
during pregnancy. However, the exact role of HspB8 in uterine muscle remains enigmatic 
and therefore there are many important research avenues left to pursue. 
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 First of all, the hTERT-HM cell line could be helpful in investigating the role of 
HspB8 as a pro- or anti-apoptotic protein throughout gestation. HspB8 could be 
overexpressed using the pCImycHspB8 expression vector used throughout this study and 
subsequently apoptotic activity could be quantified by monitoring caspase 3 activity or 
cell survival by the TUNEL method. This would help determine whether HspB8 has a 
protective function in the cell as an anti-apoptotic protein. As Bag3 has also displayed 
anti-apoptotic activity in published reports, similar experiments and assays with the 
pCIMycBag3 expression vector could also be conducted to help confirm whether Bag3 
plays an anti-apoptotic role in the myometrium. 
 HspB8 and Bag3 have been found to complex with one another in rat 
myometrium throughout pregnancy. Thus, it would also be important to determine 
whether they are part of a multiheteromeric complex comprised of HspB8, Bag3, Hsc70 
and CHIP during myometrial programming, particularly during the synthetic phase. Co-
IP experiments with protein specific antisera and affinity purified IgG (negative control) 
could be conducted to determine any temporal-specific association of Bag3 or HspB8 
with Hsc70 or CHIP. Subsequently, the multichaperone complex (Bag3-HspB8-
Hsp70/Hsc70) is thought to mediate macroautophagy in cooperation with the 
macroautophagy receptor protein p62/SQSTM1. Accordingly, it would be important to 
assess the requirement for macroautophagy in the myometrium throughout pregnancy. In 
order to determine the requirement for macroautophagy the “autophagic flux” or the 
dynamic process of autophagosome synthesis in hTERT-HM cells could be studied. The 
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amount of LC3II increases upon induction of autophagy, however, after prolonged 
autophagy activation it decreases. Therefore, reduction of GFP-labelled LC3II expression 
could be quantitated by flow cytometry in hTERT-HM cells, which inversely correlates 
with autophagic flux [267]. In order to characterize the role of HspB8 and/or Bag3 in the 
myometrium it would be helpful to overexpress HspB8 and/or Bag3 and determine their 
effect on autophagic flux in smooth muscle cells. To fully understand the process of 
macroautophagy it would also be important to look at the inhibition of autophagic 
activity and its effect on hTERT-HM cells. Commonly used PI3-kinase inhibitors such as 
wortmannin, LY294002 or 3-MA could be used to inhibit macroautophagy in vitro in 
order to assess the effects on HspB8 and Bag3, as well as their interaction [97, 268, 269].   
 Despite published reports, HspB8 overexpression in hTERT-HM cells is not 
sufficient to induce cellular hypertrophy. First, it would be important to develop a cell 
model to induce hypertrophy. The use of the ULTR cell line may be warranted. Once 
induced hypertrophy is fully verified it will be helpful to examine HspB8, Hsc70, Hsp70, 
Bag3 and CHIP gene expression, both temporally and spatially, during this process. The 
next essential step would be to use siRNA-specific knockdown of individual mRNA 
species, such as HspB8, Bag3, Hsc/Hsp70 and CHIP, prior to induction of cellular 
hypertrophy, to determine the necessity of these proteins for hypertrophic growth.  
 As previous research has indicated HspB8 may complex with HspB1 [162], 
further verification of this interaction could be important in determining the function of 
HspB8 in the myometrium throughout gestation. Once again, co-IP experiments with 
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protein specific antisera and affinity purified IgG (negative control) could be conducted 
to determine any temporal-specific association of these proteins. Additionally, a further 
investigation could be a co-immunolocalization experiment to analyze whether both 
HspB8 and HspB1 co-localize in the myometrium. Co-localization could lead to further 
confirmation of the potential interaction between these proteins, perhaps leading to the 
potential function of this heterodimeric complex. 
 HspB8 is highly expressed in mitochondria. For example, Lenne & Douce (1994) 
reported localization of HspB8 to mitochondria in pea plants [270]. Drosophilia 
melanogaster (Dm) Hsp22 was found by Morrow et al. (2000, 2004) to be a 
mitochondrial protein that was localized to the mitochondrial matrix, particularly in 
oligomeric complexes and its high level of expression in aging suggests that is may have 
a protective role during times of oxidative stress [271, 272]. Co-immunofluorescence 
detection with mitochondrial markers and an HspB8 specific antibody could be 
conducted to confirm any mitochondrial specific localization within myometrial cells. 
Human myometrial cell lines could also be used for this analysis, as the various 
organelles, such as the mitochondria, are more visible in cells.  
 Finally, throughout immunofluorescence detection it was noted that there was a 
significant amount of HspB8 expression in the endometrium. This was a novel finding, so 
in the future the expression of HspB8 could be studied throughout pregnancy in the 
endometrium. Perhaps the role of HspB8 in the endometrium would also help reveal its 
function in the uterus throughout pregnancy. 
195 
 
All of the future experiments mentioned may help to confirm the exact role of 
HspB8 and Bag3 throughout pregnancy and labour and may provide insight into reducing 
the incidence of preterm birth.   
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